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The Fragile X-related disorders arise from an unusual mutation in the X-linked 
FMR1 gene. The mutation involves expansion, or an increase in the number of repeats, 
in a CGG•CCG repeat tract located in its 5’ untranslated region. FMR1 alleles carrying 
55-200 repeats are called Premutation (PM) alleles, and cause Fragile X associated 
tremor/ataxia syndrome (FXTAS) and Fragile X-associated primary ovarian insufficiency 
(FXPOI). FMR1 alleles having more than 200 repeats are referred to as full mutation 
(FM) alleles and cause Fragile X syndrome (FXS). These different alleles arise by 
intergenerational expansion of the repeat tract from smaller unstable alleles by a 
mechanism that is unknown.  
We have shown that in addition to germ line expansion, somatic expansion also 
occurs in a human cell line in vivo and in a FX PM mouse model. In the mouse model, 
we found that the extent of somatic instability is dependent on age, gender and tissue. 
Specifically, organs such as brain, liver and gonads are susceptible to expand more 
than heart and kidney and expansion is much more frequent in males than in females.  
No differences were found between male and female mice in the levels of the 
DNA repair proteins that had already been implicated in repeat expansion in model 
systems of other disorders thought to arise via a similar mechanism. Neither were there 
any differences between males and females in the amounts of proteins produced from 
X-linked DNA repair genes. We also showed that estrogen did not protect against 
expansion. However, we found that PM alleles expanded exclusively when they were 
located on the active X chromosome. Thus some of the differences between males and 
 xii 
females in the level of somatic expansion might be due to the fact that females undergo 
X inactivation and thus have the PM allele on the inactive X chromosome in half (~50%) 
of their cells. It also indicates that transcription and/or an open chromatin configuration 
is required for expansion in the FX PM mouse.  
We also examined the effect of mutations in the DNA repair genes Msh2, Msh6 
and PolB, on intergenerational and somatic expansions in the FX PM mouse model. 
The Msh2 gene product, MSH2, interacts with MSH6 to form MutSα, one of the two 
MSH2-containing complexes found in mammalian cells. All expansions were abolished 
in Msh2 null mice and in Msh6 null mice expansions were significantly decreased. This 
suggests a role for MutSα in the repeat expansion process. Since we found that the 
PolB mutation we tested was embryonic lethal in the homozygous state, we examined 
the extent of paternal germ line and somatic expansion in heterozygous males. We 
found that even in these animals there was a significant reduction in both germ line and 
somatic expansions.  Since PolB is involved in the Base Excision Repair pathway and 
MutSα is involved in the Mismatch Repair pathway, our data suggest a model in which 
these pathways interact to generate expansions. 
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Chapter 1:  Introduction  
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1.1 The Fragile X-related disorders (FXDs) and the FMR1 gene 
The Fragile X-related disorders (FU et al. 1991; VERKERK et al. 1991; YU et al. 
1992; ALLINGHAM-HAWKINS et al. 1999; HAGERMAN et al. 2001; HAGERMAN et al. 2004) 
belong to a larger category of disorders known as the Repeat Expansion Disorders. 
These disorders comprise approximately 40 human inherited neurological, 
neuromuscular or neurodegenerative ailments that arise from the expansion of an 
unstable microsatellite repeat tract within a specific gene (PEARSON et al. 2005). These 
microsatellite repeat tracts can be of variable sequence and size and can be found in 
different locations within the affected gene, including the 3’ or 5’ untranslated regions 
(UTRs), introns and exons (Figure 1.1). These disorders have been known for decades; 
but their genetic basis was first described in 1991 when the expansion of a specific 
trinucleotide repeat was revealed to be the most common cause of Spinal and bulbar 
muscular atrophy (SBMA), a progressive neuromuscular disorder that results in muscle 
atrophy, and of Fragile X syndrome, one of the Fragile X related disorders and the 
leading cause of inherited mental disability (LA SPADA et al. 1991; VERKERK et al. 1991). 
Many other repeat expansion disorders have since been identified and the list of 
disease-causing repeats expanded to include not just trinucleotide repeats which 
constitute the majority of these disorders, but also tetra, penta, and even dodecameric 
nucleotide repeats (LALIOTI et al. 1997; MATSUURA et al. 2000; LIQUORI et al. 2001; 
PEARSON et al. 2005; MIRKIN 2006). For each of these disorders, expansions are 






Figure 1.1 Repeat Expansion Diseases in humans. Illustration of different nucleotide 
repeats that cause diseases and their locations on a generic gene. Green represents 
normal alleles, yellow signifies carriers of premutation length and red denotes disease 




The Fragile X related disorders (FXDs) include FX-associated primary ovarian 
insufficiency (FXPOI), Fragile X-associated tremor/ataxia syndrome (FXTAS), and 
Fragile X syndrome (FXS) (FU et al. 1991; VERKERK et al. 1991; YU et al. 1992; 
ALLINGHAM-HAWKINS et al. 1999; HAGERMAN et al. 2001; HAGERMAN et al. 2004). They all 
arise from the expansion of an unstable CGG•CCG-repeat tract in the 5′ UTR of the 
Fragile X mental retardation 1 gene (FMR1). They are so called because of a fragile site 
(FS), an apparent constriction or break, in the chromosome that colocalizes with the 
FMR1 gene when cells are propagated under folate stress (HECHT AND SUTHERLAND 
1985; VERKERK et al. 1991)(Figure 1.2). 
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Figure 1.2 Location of a fragile site on X chromosome. Atomic force microscopic 
image of a Fragile X chromosome showing a constriction (FS) on the X chromosome. 
The Arrow indicates the fragile site location.  
Photo Credit: Dr. Ben Oostra, Wellcome Images 
 
1.1.1 Fragile X mental retardation gene (FMR1) 
 FMR1 is a gene that is found on the long (q) arm of the X chromosome at 27.3 
(VERKERK et al. 1991). As an X-linked gene, it is subject to X chromosome inactivation 
(XCI), a phenomenon that results in random silencing of one of the two copies of the X 
chromosomes (maternal or paternal) found in females (LYON 1961; KIRCHGESSNER et al. 
1995; AVNER AND HEARD 2001). This inactivation ensures that X-linked genes are 
expressed at similar level in both males and females, a phenomenon known as dosage 
compensation. The FMR1 gene comprises 17 coding exons and can be alternatively 
spliced, resulting in different mRNAs and protein isoforms (ASHLEY et al. 1993; EICHLER 
et al. 1993; VERHEIJ et al. 1993; VERKERK et al. 1993; HUANG et al. 1996; FU et al. 2015).   
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The FMR1 gene product is called Fragile X mental retardation protein 1 (FMRP), 
an RNA binding protein (ASHLEY et al. 1993; SIOMI et al. 1993) that is expressed in the 
majority of mammalian tissues including human and mouse tissues but has elevated 
expression in neurons and gonads (GIBSON et al. 1993; VERHEIJ et al. 1993; BROWN et 
al. 1998; BAKKER et al. 2000; OOSTRA AND WILLEMSEN 2009). In mammalian cells, FMRP 
is primarily cytoplasmic although it can also occasionally be present in the nucleus 
(DEVYS et al. 1993; WILLEMSEN et al. 1996). FMRP is believed to negatively regulate the 
translation of dendritic mRNAs thus offsetting the effect of mGluR5 activation in the 
post-synaptic neuron (COMERY et al. 1997; BEAR 2005).  
1.1.2 FMR1 allele classification 
The length of the CGG•CCG repeat tract in the 5’ UTR of the FMR1 gene varies 
in the unaffected population but the most common allele has 30 repeats. Alleles with 
this repeat number have a negligible risk of expansion and are stable on 
intergenerational transmission. However, CGG•CCG repeats become unstable with 
increasing repeat number. FMR1 alleles with ~ 41-54 repeats are categorized as “grey 
zone” (GZ) or intermediate alleles (ZHONG et al. 1996; NOLIN et al. 2003; TERRACCIANO 
et al. 2004). Unlike normal alleles, intermediate alleles are slightly prone to expand on 
intergenerational transmission. They were classified as intermediate alleles based on 
their lower risk of expansion to cause FXS in one single generation (TERRACCIANO et al. 
2004). FMR1 alleles having between 55 to 200 CGG•CCG repeats are named 
premutation (PM) alleles and confer a risk of FXTAS and FXPOI. PM alleles are 
unmethylated and are hyperexpressed (TASSONE et al. 2007b). However, the expression 
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of FMRP is moderately reduced in the PM alleles despite the fact that transcription is 
elevated. It has been suggested that the decreased levels of FMRP are likely due to 
inefficient translation of the transcript when it contains large repeat numbers (FENG et al. 
1995; PRIMERANO et al. 2002; CHEN et al. 2003). 
 FMR1 alleles carrying over 200 CGG•CCG repeats are classified as full mutation 
(FM) alleles. In contrast to PM alleles, FM alleles are transcriptionally silenced. While 
many of these alleles still make some FMR1 mRNA, little or no FMRP is produced 
(PIERETTI et al. 1991; FENG et al. 1995). The absence of FMRP results in FXS (Figure 
1.3) (VERKERK et al. 1991). 
 
Figure 1.3 Relationship between repeat number, expression of FMR1 mRNA, 
FMRP, and associated diseases. PM alleles have 55 to 200 repeats and express 
elevated FMR1 mRNA levels. The level of FMRP is moderately decreased. These 
alleles confer an increased risk of developing FXTAS and FXPOI. Full mutation alleles 
have > 200 repeats. FMR1 transcription is severely reduced, resulting in no FMRP 
expression. Loss of FMR1 product, FMRP causes fragile X syndrome. Adapted from 




1.1.3 Pathology associated with FMR1 premutation alleles 
1.1.3.1 FXTAS 
FXTAS is a neurological illness associated with progressive intention tremor, 
Parkinsonism, high blood pressure, cerebellar gait ataxia, sleep apnea, dementia, 
working memory impairment, and executive dysfunction and other signs including 
peripheral neuropathy and autonomic dysfunction (HAGERMAN et al. 2001; JACQUEMONT 
et al. 2003; BREGA et al. 2008; HAMLIN et al. 2011; HAMLIN et al. 2012; HAGERMAN 2013; 
HAGERMAN AND HAGERMAN 2013; USDIN et al. 2014). Patients with FXTAS show 
characteristic radiological findings specifically, increased bilateral signal intensities of 
the middle cerebellar peduncles on T2-weighted Magnetic resonance imaging (MRI) as 
well as other abnormalities such as enlarged ventricles, brain atrophy and white matter 
changes (BRUNBERG et al. 2002; JACQUEMONT et al. 2003; COHEN et al. 2006; ADAMS et 
al. 2007). In addition, characteristic intranuclear inclusions were reported in the brain 
and testes of affected males (GRECO et al. 2002; GRECO et al. 2007). These inclusions 
were shown to contain FMR1 mRNA and numerous proteins (TASSONE et al. 2004; 
IWAHASHI et al. 2006). Both males and females are affected by FXTAS. However, 
symptoms of FXTAS are less severe in females than males due at least in part to XCI 
(BERRY-KRAVIS et al. 2005). The mechanism responsible for FXTAS pathology is not 
well understood, but is thought to arise from some detrimental consequence of the 
hyper expression FMR1 mRNA that contains a large CGG-repeat tract (HAGERMAN et al. 
2004; HAGERMAN 2013). Two current models for disease pathology are favored, one in 
which the repeats sequester CGG•CCG binding proteins and one in which the repeats 
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trigger translation at a non-canonical translation initiation codon, a process known as 
repeat associated non-AUG (RAN) translation, thereby producing a toxic protein (JIN et 
al. 2007; SELLIER et al. 2010; RENOUX AND TODD 2012; SELLIER et al. 2013)  
1.1.3.2 FXPOI 
FXPOI is a form of ovarian pathology that affects about 20% of female carriers of 
PM alleles (ALLINGHAM-HAWKINS et al. 1999; SHERMAN 2000; SULLIVAN et al. 2011; 
HAGERMAN AND HAGERMAN 2013). This malady is characterized by fertility problems, 
menstrual cycle irregularities and an earlier than normal menopause. A non-linear 
relationship was found between the numbers of CGG•CCG repeats and the age of 
menopause (ENNIS et al. 2006). PM carriers having ~80-100 repeats have the highest 
risk of developing premature ovarian failure, and thus early menopause. In addition, It 
was found that even those PM carriers who did not have FXPOI were likely to undergo 
menopause 5 years earlier than the normal population with normal FMR1 alleles 
(SHERMAN 2000). Therefore, FXPOI is a significant public health concern as premature 
menopause as been shown to increase the risk of mortality at least five fold for 
neurological disorders (RIVERA et al. 2009; SCOTT et al. 2014), and increase the risk of a 
variety of other detrimental conditions including ischemic stroke (ROCCA et al. 2012). As 
with FXTAS, FXPOI is thought to be the result of some deleterious expression of the 
mRNA containing a long CGG-repeat tract. 
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1.1.4 Pathology associated with FMR1 full mutation alleles 
1.1.4.1 FXS 
FXS is the leading common heritable cause of intellectual disability. Its 
prevalence in the normal population is approximately 1 in 4000 males and 1 in 5000-
8000 females (LYONS et al. 2015). It was first documented in 1943 by Martin and Bell as 
a X-linked mental retardation disorder (MARTIN AND BELL 1943). Symptoms of FXS 
include a learning disability that is often severe, developmental delay, hyperactivity, 
depression and anxiety (CORNISH et al. 2001). FXS is associated with autistic features 
and in fact is the major known monogenic source of autism (HATTON et al. 2006). In 
addition, patients affected with FXS often exhibit distinctive physical features such as a 
prominent jaw, large ears, large testes and elongated face (BUTLER et al. 1993). While 
both men and women are affected with FXS, females tend to be less affected because 
they are heterozygous and that the second X chromosome confers some protective 
effect on them (DE VRIES et al. 1996; BENNETTO et al. 2001; BERRY-KRAVIS et al. 2005). 
The full mutation usually leads to the silencing of the FMR1 gene and the absence of 
FMRP (PIERETTI et al. 1991; DEVYS et al. 1993; VERHEIJ et al. 1993). Some non-repeat 
associated FMR1 mutations, including missense and splice site mutations as well as 
deletions also cause FXS (DE BOULLE et al. 1993; HAMMOND et al. 1997; PIMENTEL 
1999). 
The mechanism by which CGG•CCG repeats expand from a normal allele to a 
PM allele or from a PM to a FM allele is unknown. However, numerous risk factors for 
expansion have been identified in humans as well as in mouse models. (SHERMAN et al. 
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1984; OBERLE et al. 1991; ROUSSEAU et al. 1991). The size of repeat is one of the most 
important risk factors for expansion. The larger the PM allele the more likely it is to 
expand to a FM in one generation (HEITZ et al. 1992; YU et al. 1992; FISCH et al. 1995).  
Parental gender is also an important factor. While smaller alleles are more likely to 
expand on paternal transmission, transmission of the FM allele from a PM allele occurs 
exclusively on maternal transmission (SHERMAN et al. 1984; OBERLE et al. 1991; 
ROUSSEAU et al. 1991). This is likely due to contraction of large expansions in sperm 
(MALTER et al. 1997). Beyond the repeat size and the gender of the transmitting parent, 
population and family studies have reported other factors that play a role in FX repeat 
instability including the presence, number and location of AGG interruptions as well as 
potential cis and trans-acting factors related to haplotype background (SNOW et al. 
1994; NOLIN et al. 2003; NOLIN et al. 2013; LATHAM et al. 2014). 
 
1.2 Repeat expansion background 
Instability in Repeat Expansion Diseases shows a strong expansion bias, 
although contractions of the repeat are also observed (DE BOULLE et al. 1993; DE 
GRAAFF et al. 1995; ENTEZAM et al. 2007). The tendency of the repeat to expand on 
intergenerational transmission results in the phenomenon of anticipation in which the 
disease severity increases with successive generations and an earlier age of onset of 
symptoms is seen.  
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In addition to repeat expansion on intergenerational transmission, expansion has 
also been reported to occur in somatic cells throughout the life span of an individual in 
many Repeat Expansion Diseases. Several of these diseases show increased levels of 
somatic instability particularly for bigger alleles (TELENIUS et al. 1994; MORALES et al. 
2012). The expansion of the unstable repeat in somatic cells is generally age-
dependent. However, the pattern of repeat expansion is not uniform in different organs 
of the same individual with some organs being more prone to expansion than others 
(TELENIUS et al. 1994). Recent work in some Repeat Expansion Diseases suggests that 
somatic expansion can contribute to the age of the disease onset and severity of the 
symptoms (SWAMI et al. 2009). In the Fragile X-related disorders (FXDs) somatic 
mosaicism is often seen (PIERETTI et al. 1991; PRETTO et al. 2014). However, whether 
this results from somatic expansion of smaller alleles or contraction of larger ones is 
unknown.  
1.2.1  Expansion-prone repeats form secondary DNA structures  
The disease-associated repeats are able to adopt unusual conformations, 
including triplexes, tetraplexes, slipped strand structures and hairpins (Figure 1.4). 
These structures are believed to form whenever the DNA becomes single-stranded 
such as during transcription or replication (MIRKIN 2006). Single-stranded DNA 
containing CNG repeats, where “N” is any nucleotide, can fold into hairpin-like 
structures made up of a combination of Watson-Crick base pairs and mismatched base 
pairs in a 2:1 ratio (Figure 1.4a) (GACY et al. 1995; MITAS et al. 1995; USDIN AND 





Figure 1.4 Different DNA conformations formed by unstable repeats. (a) Hairpin 
structure made-up of (CNG)n repeat. (b) G-quartets conformation formed by (CGG)n 
repeats (c) Slipped (S) DNA (d) Different triplexes made with (GAA)n repeats (other 




In addition to hairpin-like structures, the individual strands of the GC-rich repeat, 
including the CGG and CCG can also adopt other unusual DNA conformations (USDIN 
AND WOODFORD 1995). For example, a quadruplex-like structure (G-quartets structure) 
(Figure 1.4b) can be formed when an unpaired DNA strand of CGG•CCG repeats fold 
into a tetra-helical structure that is stabilized by G quartet motifs (MITAS et al. 1995; 
USDIN AND WOODFORD 1995; PEARSON AND SINDEN 1996; MIRKIN 2007). Slipped DNA 
structures can arise when the two DNA strands reanneal out of register resulting in 
hairpins or loopouts on both strands (Figure 1.4c). GAA•TTC repeats can also form 
different sorts of intramolecular triplexes (1.4d), a type of three-stranded DNA structure 
(GACY et al. 1998). 
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Interruptions to the purity of the repeat tract reduce the stability and length of the 
secondary structures that can be formed. These interruptions decrease the risk of 
expansion in many Repeat Expansion Diseases (EICHLER et al. 1995). For example, in 
the FXDs, AGG interruptions increase the stability of the repeat tract during maternal 
transmission (NOLIN et al. 2003). 
1.2.2 Mechanisms implicated in repeat instability  
The mechanism(s) responsible for repeat expansion and contraction on either 
intergenerational transmission or in somatic tissues are poorly understood. However, 
several hypotheses have been proposed for both expansion and contraction. Most of 
these hypotheses are founded on the idea that unusual secondary DNA structures 
formed by the expansion-prone repeats result in instability as a result of problems that 
arise during different DNA metabolic processes including DNA replication, 
recombination or repair. However, evidence from several model systems and affected 
humans suggests that expansion does not result from a problem with chromosomal 
DNA replication per se. For example, in diseases like Myotonic Dystrophy type 1 (DM1), 
Huntington disease (HD), and Friedreich ataxia (FRDA), expansions are seen in organs 
with a low proliferative capacity such as kidney, as well as in non-dividing cells such as 
neurons or gametes (TELENIUS et al. 1994; THORNTON et al. 1994; LIA et al. 1998; DE 
BIASE et al. 2007; VAN DEN BROEK et al. 2007; GONITEL et al. 2008). In addition, in a 
mouse model for HD, expansions are seen in post-meiotic, haploid germ cells (KOVTUN 
AND MCMURRAY 2001). In addition, in both the FXDs and DM1, there is a strong 
maternal age effect on expansion risk (YRIGOLLEN et al. 2012; MORALES et al. 2015). 
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This indicates that expansions in these disorders can occur in the oocyte, another cell 
type that does not divide. These data favor the hypothesis that expansion arises from 
certain problems during DNA repair or recombination rather than chromosomal DNA 
replication per se. 
Many different DNA repair pathways operate in mammalian cells. These 
pathways include base excision repair (BER), homologous recombination (HR), 
mismatch repair (MMR), nucleotide excision repair (NER), non-homologous end joining 
(NHEJ) (SANCAR et al. 2004). While work in vitro, and in bacteria and yeast, suggest 
that many of these processes can in theory produce expansions; MMR and BER are the 
major pathways that have been suggested to cause expansion in mouse models. 
1.3 MMR and BER Implication in repeat instability 
1.3.1 The mismatch repair pathway 
MMR is the major pathway for the repair of base substitution mismatches and 
insertion-deletion mismatches (IDLs) introduced during DNA replication in prokaryote 
and eukaryote organisms (KOLODNER AND MARSISCHKY 1999; IYER et al. 2006). Some of 
the MMR components participate in a number of other processes of DNA repair 
including homologous recombination, somatic hypermutation and interstrand-crosslink 
repair. 
In mammalian cells, MSH2, a key component of the MMR pathway, hetero-
dimerizes with either MSH6 to form a MutSα complex or with MSH3 to form a 
MutSβ complex. MMR repair is initiated by recognition of the mismatch by these 
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heterodimers (KUNKEL AND ERIE 2005). The recognition properties of MutSα are different 
from that of MutSβ heterodimers, with MutSα preferentially recognizing base-base 
mismatches and insertion/deletion mismatches (IDL) of 1-2 nucleotides, while MutSβ 
can also recognize insertion/deletions (IDL) involving several extra nucleotides 
(MCCULLOCH et al. 2003).  
After recognition of the mismatch, a MutL complex is then recruited (LI 2008). 
Mammalian cells contain 3 MutL complexes: MutLα , MutLβ, and MutLγ . These 
complexes are heterodimers involving MLH1 and PMS1, PMS2 or MLH3. While 
MutLα (MLH1-PMS2) is known to play an important role in repairing various 
mismatches, MutLγ (MLH1-MLH3) is involved in repairing IDLs (FLORES-ROZAS AND 
KOLODNER 1998) and involved in meiotic recombination (SANTUCCI-DARMANIN AND 
PAQUIS-FLUCKLINGER 2003). The role of MutLβ (MLH1-PMS1)  is not yet understood 
(KOLODNER AND MARSISCHKY 1999). The MutS/MutL complex then interacts with the 
proliferating cell nuclear antigen (PCNA) (CLARK et al. 2000). This interaction leads to 
the activation of the endonuclease activity of MutL that results in the formation of a nick 
in the vicinity of the mismatch. Exonuclease 1 (EXO 1) is then recruited to the nick and 
creates a single-stranded gap. This gap is then filled by DNA polymerase δ (Polδ), and 
the MMR is completed when the nick is ligated using DNA ligase I (Lig1) (KUNKEL AND 
ERIE 2005; LI 2008).    
Mutations in MMR genes increase genome wide microsatellite instability (MSI) 
and are the leading cause of many hereditary and sporadic cancers in humans 
(MODRICH AND LAHUE 1996; KOLODNER AND MARSISCHKY 1999; POYNTER et al. 2008). For 
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example, germ line mutations of the MMR genes MSH2, MSH6, MLH1 and PMS2 have 
been linked to hereditary cancers including hereditary non-polyposis colorectal cancer 
(HNPCC) or Lynch syndrome (LYNCH et al. 1985; ABDEL-RAHMAN et al. 2006; RAHNER et 
al. 2013). While mutations in key MMR genes result in increased MSI, work in various 
model systems of some Repeat Expansion Diseases has shown variable effects of 
mutations in different genes involved in MMR on repeat expansion.  
For instance, in a mouse model of DM1, loss of MSH2 eliminated repeat 
expansion in both germline and somatic cells (VAN DEN BROEK et al. 2002; SAVOURET et 
al. 2003), while in a transgenic mouse model of HD loss of MSH2 eliminated somatic 
expansions and paternal but not maternal expansions (MANLEY et al. 1999b; KOVTUN 
AND MCMURRAY 2001; WHEELER et al. 2003). However, in a mouse model of Friedreich 
ataxia (FRDA), MSH2 was shown to protect against intergenerational repeat 
contractions (EZZATIZADEH et al. 2012), but contributed to somatic expansion in these 
mice (BOURN et al. 2012). In induced pluripotent stem cells (iPSCs) from FRDA patient 
fibroblasts cells, shRNA silencing of MSH2 prevented repeat expansion (KU et al. 2010; 
DU et al. 2012). 
The effect of the loss of MSH3 and MSH6 on repeat expansion was also 
examined in various mouse models of some Repeat Expansion Diseases. While the 
loss of MSH3 significantly decreased all repeat expansions in the mouse models of 
DM1 (FOIRY et al. 2006), in a HD model loss of MSH3 decreased somatic expansions 
but not germ line expansions (DRAGILEVA et al. 2009), while in a FRDA mouse model 
MSH3 was shown to protect against contractions. Loss of MSH6 did not reduce either 
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germ line or somatic expansions in either HD or DM1 mouse models (VAN DEN BROEK et 
al. 2002; FOIRY et al. 2006; DRAGILEVA et al. 2009). In contrast, in a mouse model of 
FRDA, MSH6 was shown to protect against both expansions and contractions in the 
germline but contributed to expansions in somatic cells (BOURN et al. 2012; DU et al. 
2012).  
The molecular basis by which the MMR proteins act to promote repeat expansion 
remains to be elucidated. One suggestion is that MutSβ promotes expansion by its 
ability to bind and stabilize the hairpin structure instead of processing the mismatches 
by the MMR pathway as illustrated in figure 1.5 (OWEN et al. 2005). This model, which is 
also referred to as the “hijacking“ model is based on the fact that binding of MutSβ to 
secondary structures formed by repeats inhibits its ATPase activity. It has been 
proposed that this leads to defects in downstream signaling that in turn result in error-
prone DNA repair that result in incorporation of unrepaired loops as expansions (OWEN 
et al. 2005; MCMURRAY 2008; LANG et al. 2011). However, this model was challenged 
when subsequent studies with slightly different substrates did not show such inhibition 
(TIAN et al. 2009). Furthermore, it was also shown that the ATPase domain is required 
for expansion in a DM1 mouse model (TOME et al. 2009). This finding suggests that the 
role of MMR in promoting expansion is not confined to the recognition or binding of 
hairpins by MutSβ (TOME et al. 2009). This idea is strengthened by recent work that 
implicates MutLα and MutLγ in the expansion process (GOMES-PEREIRA et al. 2004; 
PINTO et al. 2013; EZZATIZADEH et al. 2014).  
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1.3.2 Base Excision Repair 
Base Excision Repair (BER) was discovered about ~40 years ago by Tomas 
Lindahl (LINDAHL 1974; FRIEDBERG AND LINDAHL 2004). This pathway is responsible for 
repairing base lesions that are caused by oxidation, deamination, alkylation, 
depurination or depyrimidination (ROBERTSON et al. 2009). The BER pathway is initiated 
by the recognition of a damaged base by an appropriate DNA glycosylase. This DNA 
glycosylase catalyzes the cleavage of an N-glycosidic bond, effectively excising the 
damaged base that leads to the creation of an apurinic or apyrimidinic site (AP site) (LU 
et al. 2001). The AP site is subsequently processed by the AP Endonuclease 1(APE1), 
an endonuclease that cleaves the DNA phosphodiester backbone and generates a 
single-stranded DNA nick 5’ to the AP site. The AP site can also be processed by a 
DNA AP lyase of some DNA glycosylases creating a nick 3’ to the AP site.  
The processing of the AP site leads to creation of single nucleotide gap in the 
DNA that contains a 3’ hydroxyl and 5’ deoxyribose phosphate group (dRP) (ASPINWALL 
et al. 1997; DIANOV et al. 2003). The gap is processed via the single nucleotide BER 
(SN-BER) pathway when the 5’ deoxyribose phosphate group is not oxidized. In this 
case, DNA polymerase beta (Polβ), a key enzyme of the BER pathway that possesses 
both 5′dRP lyase and gap-filling activities, inserts a single nucleotide with the resultant 
nick being sealed by DNA ligase I (Lig 1) (LIU AND WILSON 2012). However, if the AP site 
or the 5’ phosphate group is oxidized or reduced, an alternate sub-pathway, long patch 
BER (LP-BER), is used for repair. 
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In vitro work has led to the suggestion that LP-BER could lead to expansion via a 
“hit and run” mechanism (LIU et al. 2005) and as illustrated in figure 1.5B(USDIN et al. 
2015),involving the coordination of Polβ and Flap Structure-Specific Endonuclease 1 
(FEN1) in a process of stepwise single-nucleotide gap-filling synthesis by Polβ with the 
resultant small flaps being partially removed by FEN1 to generate a ligatable 5’ end (LIU 
et al. 2005). FEN1 is a DNA repair protein that plays an essential role in maintaining the 
genome stability by removing DNA flaps during DNA replication and repair (KLUNGLAND 
AND LINDAHL 1997). An alternate pathway involving the coordinated processing of 
slipped hairpins by a combination of Polβ and Polδ has also been suggested as a 
source of expansions (CHAN et al. 2013). 
Evidence that BER generates expansions has come from the demonstration that 
OGG1 (KOVTUN et al. 2007) and NEIL1 (MOLLERSEN et al. 2012), DNA glycosylases 
involved in the early steps of BER reduce the extent of somatic expansion. However, 
loss of OGG1 did not affect germ line expansions while the loss of NEIL1 reduced the 
average size of the expansions but not their frequency. This has led to the suggestion 
that the contribution of BER to the expansion process may be limited to the generation 





Figure 1.5 Expansion models involving both MMR and BER. (A) MMR pathway: 
MutS complexes bind to the hairpin formed by the repeats. PCNA and MutLα also bind 
to MutS complexes to form a ternary complex. MutLα nicks the top or bottom strand. 
This is followed by the generation of a gap by EXO1 that extends past the hairpin, DNA 
synthesis to fill the gap and then sealing of the nicks by Lig1. The repair leads to an 
expansion on both strands. (B) BER pathway: DNA glycosylase binds to oxidized base, 
followed by creation of a nick by Ape1. Polβ alone or in combination with Polδ, Polɛ, or 
Polη performs gap filling DNA synthesis that can result in expansion (left pathway). 
Hairpins can obstruct FEN1 cleavage (shown by pink dotted FEN1), preventing flap 
cleavage (shown by red solid FEN1) and leading to expansions as well. Expansions 




1.4  The Fragile X PM Mouse model  
Several transgenic mouse models have been generated to study the mechanism 
of CGG•CCG repeat instability. However, these mouse models showed little repeat 
instability upon intergenerational transmissions (LAVEDAN et al. 1997; BONTEKOE et al. 
2001). To attempt to model the mechanism of repeat instability in mice, the Usdin 
laboratory generated a PM mouse model in which the endogenous murine repeat tract 
was replaced by a fragment containing ~130 CGG•CCG repeats (ENTEZAM et al. 2007). 
This mouse model recapitulates several key features seen in human carriers of PM 
alleles including the elevated levels of Fmr1 mRNA, the reduced levels of FMRP, the 
presence of ubiquitin-positive intranuclear inclusions in the brain, Purkinje cell loss, as 
well as a high frequency of intergenerational expansion (ENTEZAM et al. 2007).  
Using this mouse model, the Usdin laboratory has shown that mutations in ATM 
(Ataxia-Telangiectasia, Mutated) and ATR (ATM and Rad3-related), the two kinases 
responsible for regulating the response to DNA damage and stalled replication forks 
increase repeat expansion (ENTEZAM AND USDIN 2008; ENTEZAM AND USDIN 2009). 
Furthermore, they have showed that oxidative damage exacerbates germ line repeat 
expansion (ENTEZAM et al. 2010). They also showed that Transcription Coupled Repair 
(TCR) is not involved in generating repeat expansion in the FX PM mice (ZHAO AND 
USDIN 2014).  
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1.5 Thesis Objectives/outline 
The study described in this thesis attempts to shed light on the expansion 
mechanism responsible for the Fragile X-related disorders. The work presented extends 
previous work in the Usdin laboratory aimed at understanding the somatic instability of 
the PM alleles along with genetic factors that impact both germ line and somatic repeat 
expansion(ENTEZAM AND USDIN 2008; ENTEZAM AND USDIN 2009). 
Transcription or an open chromatin conformation facilitates expansion in FX PM 
mice. 
A previous doctoral student in the Usdin laboratory observed somatic expansion 
of the CGG•CCG repeat in FX mice that seemed more extensive in males than in 
females. However, it was not clear why some organs were more prone to expand than 
others and why somatic instability was less prevalent in females. Chapter 2 describes 
my examination of CGG•CCG repeat instability in different organs of male and female 
mice and of different potential expansion risk factors that might explain the tissue 
differences and effects of gender. The results presented indicate that a major 
contributor to the gender bias in the expansion frequency was the fact that expansion 
does not occur on the inactive X chromosome. This suggests that expansion of the 
CGG•CCG repeat in PM mice requires transcription or an open chromatin configuration. 
However, XCI does not explain all the gender difference and we did not identify any 
gender-specific differences in expression of DNA repair proteins that could account for 
the residual excess of expansions in males. However, tissue differences in the levels of 
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various key DNA repair proteins did suggest a basis for some of the differences in the 
propensity of different organs to show expansions. 
The Mismatch Repair proteins MSH2 and MSH6 promote expansion in FX PM 
mice  
The role that MMR proteins play in CGG•CCG repeat expansion was not known. 
Evidence presented in chapter 3 and 4 suggests that MutSα  protects the genome 
against repeat contractions. It also promotes repeat expansions, but does so in a 
MutSβ-dependent way. 
PolB also facilitates expansion of the PM alleles 
Previous work in the Usdin laboratory indicated that potassium bromate, a 
powerful oxidizing agent, exacerbated germ line expansion in the CGG•CCG repeat, 
suggesting the role of oxidative damage in promoting expansion. Results presented in 
chapter 5 demonstrate that central events in the BER pathway, the major pathway by 
which oxidative damage is repaired in mammalian cells, is also involved in CGG•CCG 
repeat expansion (MOLLERSEN et al. 2012).   
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Chapter 2:  Somatic instability of PM alleles in a human PM 




A hallmark of all Repeat Expansion Disorders is the propensity of the disease-
associated repeat to undergo expansion in the germ line (HEITZ et al. 1992; PEARSON et 
al. 2005). However, somatic expansion has also been reported in some of these 
diseases. These expansions are described as dynamic mutations since they induce a 
continuous change of the repeat size in successive generations and throughout the life 
span of an affected individual. The molecular basis underlying the mechanism of repeat 
expansion in either germ line or somatic cells remains to be elucidated. However, many 
studies have shown that the expansion prone repeats form secondary structures (GACY 
et al. 1995; MITAS et al. 1995; GRABCZYK AND USDIN 1999; MIRKIN 2006; MIRKIN 2007; 
USDIN 2008), and the current thinking is that expansions are generated by the aberrant 
processing of these secondary structures as stated above (Figure 1.4). 
Somatic expansion has been reported in patients with other Repeat Expansion 
Diseases and in mouse models of these diseases (TELENIUS et al. 1994; CHONG et al. 
1995; UENO et al. 1995; MANLEY et al. 1999a; TANAKA et al. 1999; DE BIASE et al. 2007; 
VAN DEN BROEK et al. 2007). Data from these studies suggest that expansion of the 
repeat tract in the somatic cells can exacerbate disease severity and reduce the age of 
onset of these diseases, e.g., in the case of DM1 (MORALES et al. 2012) and in HD 
(WHEELER et al. 2003; SWAMI et al. 2009). Somatic mosaicism has been observed in 
human carriers of the FX PM and FM alleles (PIERETTI et al. 1991; PRETTO et al. 2014), 
but it was unknown whether this reflected contractions from larger alleles or expansions 
from smaller ones.  
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Somatic expansion of the FX PM alleles in mice was previously observed in our 
laboratory(ENTEZAM AND USDIN 2008; ENTEZAM AND USDIN 2009). However, this 
phenomenon was not studied extensively. Since a correlation exists between repeat 
number and disease symptoms as well as a direct relationship between repeat number 
and the likelihood of further expansion (ASHLEY-KOCH et al. 1998; TASSONE et al. 2007a; 
NOLIN et al. 2011), somatic expansion may be a clinically relevant phenomenon. 
We therefore assessed somatic expansion in human cells using genomic DNA 
that had been previously extracted by Dr. Daman Kumari in the Usdin laboratory. We 
also assessed somatic expansion in different organs of male and female mice. This 
work showed that somatic expansions of the FX PM alleles can occur in both human 
cell lines and mice. We also showed that in mice somatic expansion is age-dependent, 
tissue-specific, and gender-biased. In addition, we have identified factors that account, 
at least in part, for some of these differences. 
2.2 Results: 
2.2.1 Expansion is seen in a human lymphoblastoid cell line 
To investigate whether expansion can occur in human somatic cells, we used the 
PCR to amplify 100 ng of genomic DNA that had been isolated from lymphoblastoid 
cells cultured in vitro. We used the primer pair Frax AF and Frax F-Hex to amplify 
across the repeat as detailed in the Materials and Methods chapter. The PCR products 
were resolved on a 3130XL Genetic Analyzer and analyzed using GeneMapper 4.0 
software. PCR amplification across the CGG•CCG repeat generates multiple PCR 
products that appear in GeneMapper profiles as a cluster of peaks differing by a single 
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repeat unit (Figure 2.1). Some of these peaks represent strand-slippage products that 
are generated when amplifying through long repeat tracts. The PCR products smaller 
than the original allele that do not change with genotype, age or tissue are likely to fall 
into this category. However, products that are larger than the main alleles primarily 
represent expansions since they increase with age and are absent in PCR profiles 
generated from mice with null mutation in genes, like Msh2 or Msh3, that eliminate 
expansion as discussed in the next chapter and shown in Figure. 2.1. 
Analysis of the human cell line revealed that the original allele (0 month) had 
~118 repeats (Figure 2.2). At 24 months, the single peak seen in the original culture had 
been replaced with alleles that had gained ~16, ~35 or ~51 repeats resulting in alleles 
with ~ 136, 150, and 169 repeats respectively. At 42 months, alleles carrying 160, 177, 
182, and 208 repeats were apparent. These alleles were ~45, ~62, ~77 and ~93 
repeats larger than the original allele, respectively. Their amplification yield was low 
compared to the yield of PCR product from alleles detected at 24 months. This is likely 
due to some combination of the increased heterogeneity of alleles in the population, 
together with the fact that alleles with larger repeat numbers are more difficult to 
amplify. Thus, expansion in this cell line seemed to have occurred in a series of 
successive jumps that over a period of 3+ years resulted in the conversion of a PM 




Figure 2.1 Illustration of the CGG•CCG repeat PCR product profiles in WT and 
Msh2-/- mice. GeneMapper Scan showing a PCR profile of a FX PM allele in an Msh2-








Figure 2.2 Expansions in a human PM lymphoblastoid cell line. GeneMapper scans 
showing in vivo expansion of FX PM repeats of the lymphoblastoid cell line after 
recurrent growth in cell culture for about 3 years. t represents different time points: t0 = 
0 month, t1= 24 months, and t2= 42 months. A LIZ1200 standard was included (orange 
peaks) in all samples. The lower panel shows all 3-time points superimposed on one 
another. The red peak represents the original allele at time zero and the green and blue 
peaks correspond to the 24 and 42-months time points. The dotted vertical line 




2.2.2 The extent of somatic expansion varies in different organs of male 
mice. 
To investigate somatic instability in FX PM mice, we isolated genomic DNA from 
different organs of male mice at different ages. The initial repeat number in these 
animals was ~140. The genomic DNA was amplified by fluorescent PCR, resolved on a 
3130XL Genetic Analyzer and analyzed using GeneMapper 4.0 software, as detailed in 
the Materials and Methods chapter. Somatic expansion was examined by comparing 
the repeat PCR profile in animals 2, 4 and 12 months old to the repeat profile seen in 
the tail DNA of the same animals at three weeks of age (tail 1). We also quantified the 
extent of somatic expansion using the somatic instability index (SII), a quantitative 
measure of the level of somatic instability developed in the Wheeler laboratory (LEE et 
al. 2010). 
In the 2-month-old animals the PCR profiles of liver and testis showed a small 
shift to the right compared to the other organs, consistent with a low level of expansion 
(Figure 2.3.A). At 4 months of age, a moderate level of somatic expansion is seen in the 
brain, liver, and testis as evidenced by the further right shift of the PCR profile (Figure 
2.3 A) and the positive SII values (Figure 2.3 B). Extensive level of somatic expansion is 
seen at 12 months of age (figure 2.3AB). Two widely separated peaks were seen in 
some organs like liver and testis, one corresponding to the original inherited allele, and 
another corresponding to a significantly larger allele. In other organs (e.g., brain), the 
increase in size of the expanded alleles was more modest. These two different types of 
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expansion profiles would be consistent with the idea that expansions can involve small 
“jumps” or large “jumps” depending on the organ involved 
 
 
Figure 2.3 Expansions in different organs of male mice. A) Scans showing 
repeat expansion profile in organs of mice at 2, 4,and 12 months of age. The 
inherited parental allele based on the repeat number in the tail DNA taken at 
weaning age (tail 1). Tail 2 refers to tail taken after euthanasia. The repeat DNA 
profiles were generated using a Fam (blue) or Hex labeled primer (green).  
LIZ600 or LIZ1200 (orange) and Rox 500 molecular weight markers were used. 
B) Graph indicating the average somatic instability index (SII) in different organs 
of male mice at 2 (n=5), 4 (n=3) and 12 months (n=5). These mice had between 
141 and145 repeats. 
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2.2.3  Somatic expansion is less extensive in female mice 
To investigate whether the extent of somatic expansion is similar in female and 
male mice, we extracted genomic DNA from different organs of 8 female and 8 male FX 
PM mice. These mice were age-matched (12 months old) and all carried ~ 148 repeats. 
We then examined the PCR profile in different organs as described in the Material and 
Methods chapter. We found that while the same tissues were prone to expand as in 
males, expansion was much less extensive in females (Figure 2.4 A and B). Even in 24-
month-old females less expansion was seen than in 12-month-old males (Figure 2.4 A 




Figure 2.4 Gender bias of somatic expansions in the FX PM mice. A) 
Representative GeneMapper scans showing the expansion status in the indicated 
organs of a 12-month old male mouse. B) GeneMapper scans showing expansion 
profile in designated organs of a female mouse of same age and repeat number. 
C). GeneMapper scan showing the extent of expansion in a 24-month-old female 
carrying 143 repeats. The red arrow and the dotted lines show the mobility of the 
original inherited allele. Either LIZ600/1200™ (orange) or ROX 500™ (red) size 
standards were used; the GeneMapper profile was not affected in anyway by the 
choice of the marker used. While tail 1 indicates the tail sample cut at 3 weeks, tail 




The difference in the level of expansion in females versus males can perhaps be 
seen more clearly when PCR profiles from age and repeat-matched animals are 
overlaid (Figure 2.5A). We also measured the Somatic Instability Index (SII) in females 
and males. The SII in males was 2.9 fold higher in brain, 4.6-fold higher in liver and 6.8-
fold higher in gonads than it was in females (Figure 2.5B). 
 
 
Figure 2.5 Gender bias of somatic expansions in the FX PM mice. A) 
Superimposed GeneMapper scans from the heart and indicated expansion prone 
organs of a 12 month old male and a female mouse. Both animals carried ~146 
repeats. The red arrowhead and the dotted line indicate the mobility of the 
inherited parental allele. B) Average somatic instability index in indicated organs 
of one year old males (n=8) and females (n=8) carrying ~145 repeats. Tail 1 
indicates the tail sample taken at 3 weeks old, at weaning; while tail 2 refers to 




Since males and females show differences in the extent of expansion but are 
similar in terms of what organs are expansion-prone, it suggests the existence of both 
tissue and gender-specific factors that contribute to expansion risk. 
2.2.3.1 Factors contributing to FX PM repeat expansion 
2.2.3.1.1 XCI contributes to the reduced SII seen in FX PM female mice 
XCI is the process by which one of the two copies of the X chromosome present 
in female mammals is silenced (LYON 1961). As the Fmr1 gene is located on the X 
chromosome, it is possible that some of the gender differences seen in the FX PM 
mouse could be due to the fact that the PM allele will be on the inactive X chromosome 
in approximately half of cells in females heterozygous for PM. To test this hypothesis, 
we developed an assay that allowed us to specifically look at the PCR profile of inactive 
alleles. This assay took advantage of the fact that a methylation-sensitive restriction 
enzyme, Sau96I, contains a recognition site in one of the primers (Frax m5) used for the 
repeat PCR. 
 Genomic DNA from brain and gonads of female and male PM mice was either 
undigested or digested with Sau96I as described in the Material and Methods section. 
Since males have only one X chromosome, this chromosome is active and hence has 
an unmethylated Sau96I site. Therefore, complete Sau96I digestion will prevent 
amplification of the repeat in males. In females, ~50% of the X chromosomes will 
remain after digestion. Following DNA digestion, ~100 ng of undigested and digested 
DNA was used in the FX PM PCR assay as described in the Materials and Methods 
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chapter. The PCR products were resolved by capillary electrophoresis (CE) on an ABI 
Genetic Analyzer and the PCR profiles analyzed using GeneMapper 4.0 Software. The 
GeneMapper scan of the undigested female sample represents a profile of the repeats 
that are located on the active and inactive X chromosomes, whereas the PCR profile 
generated after digestion of the female sample with Sau96I represents the repeats 
located on the inactive X chromosomes only.  
No PCR amplification of the PM allele was seen in the male DNA samples 
digested with Sau96I (Figure 2.6), congruent with the observation that in males there is 
only one X chromosome and this chromosome does not undergo XCI. However, in 
females a PCR profile could be seen in both undigested and digested DNA. This is 
consistent with the fact that the PM allele is found on the inactive X chromosome in 
approximately half of cells of heterozygous females and is therefore resistant to Sau96I 
50% of the time. Expansions were seen in the undigested DNA as shown by the 
presence of PCR products larger than the original allele (Figure 2.6). However, there 
was no expansion observed in the digested samples. Thus, repeat expansion in tissues 
of female PM mice is seen exclusively when the PM allele is located on the active X 
chromosome. These data suggest a requirement for transcription or the presence of the 






Figure 2.6 Somatic expansions on active and inactive X chromosomes. 
Representative GeneMapper profiles showing expansion in two males (1 brain, 1 testis) 
and two females (1 brain, 1 ovary) without (-) and with (+) digestion with Sau96I. The 





2.2.3.1.2 Skewed XCI does not explain differences in female SII. 
While our data indicate that XCI contributes to the gender biases in the degree of 
expansion, the >2-fold differences in the SII between males and females (Figure 2.5B) 
cannot be completely explained by this factor alone, unless there was significant 
skewing of XCI.  To test this idea, we examined X chromosome inactivation ratios in the 
brain tissues of 7 different PM females with SII ranging from 1.3 to 3.1. These SII values 
span the range of SII values seen in the brain of female mice. 
To do this, we used a modification of the assay we used previously to examine 
XCI. In this assay, genomic DNA from the brain samples of female mice were digested 
with or without EaeI, a methylation-sensitive restriction enzyme that possesses a 
recognition site in the neomycin gene that is located downstream of the repeat in intron 
1 (ENTEZAM et al. 2007). This gene was inserted along with the premutation repeats 
when the mouse line was originally made. Following digestion, the undigested and 
digested samples were amplified using a real-time PCR assay, as explained in the 
Materials and Methods chapter. The ratio of the yield of the digested DNA amplicons to 
the yield of the same amount of undigested material was used to determine the X 
inactivation ratio. 
Three out of 7 females showed an X inactivation ratio of ~50:50 (active X: 
inactive X), 2 out of 7 showed a ~30:70 ratio, 1 female showed ~20:80 ratio, and 1 
showed an 80:20 ratio. On average, the PM allele was found to be located on the active 
X chromosome ~ 44% of the time. We did not find a good correlation between whether 
the PM allele was located on the active chromosome and the level of somatic expansion 
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(Figure 2.7). For example, the three mice with the average SII of ~ 3.0 (F5, F6, and F7) 
in the brain, had the PM allele located on the active X chromosome ~32% of the time in 
one case, ~49% of the time in the second, and 80% of time in the third case. Similarly, 
the two brain samples with the lowest SII (1.3, F1 and F2) had the PM allele located on 
the active X chromosome, 45% and 20% of the time. These data indicate that X 
inactivation does not completely account for the gender differences in the levels of 
somatic expansion that is seen in the FX PM mice. Thus, there must be additional 
gender-specific factors that contribute to expansion risk.  
 
Figure 2.7 SII and XCI ratios in FX PM female mice. GeneMapper profile and Somatic 
instability index (SII) showing the degree of expansion in brain relative to XCI in one-
year-old female mice. The XCI ratio is shown as the fraction of the PM allele that is 
located on the active X versus the fraction of the PM alleles located on the inactive X 




2.2.3.1.3 Some MMR and BER proteins correlate with SII in different organs.  
A number of proteins implicated in DNA repair have been shown to be important 
for repeat expansion in various mouse models of the Repeat Expansion Diseases 
(MANLEY et al. 1999b; SAVOURET et al. 2003; KOVTUN et al. 2007; MOLLERSEN et al. 
2012; LOKANGA et al. 2014). To test whether the levels of tissue-specific expression of 
these proteins could explain the propensity of some organs to expand, we examined the 
levels of these and other proteins in the brain, heart, liver, kidney and testis of male 
mice at 6 months of age by Western blot.  
As can be seen from Figure 2.8A, neither the levels of MSH2 nor MSH3 
correlated completely with the extent of expansion in different organs. For example, 
while expansion is more extensive in liver than in kidney, the level of MSH2 was higher 
in kidney while the levels of MSH3 are similar in these two organs. However, when 
MSH2, MSH3 and MSH6 are considered together, a correlation is seen. Of all the 
proteins tested in the BER pathway, only APE1 and FEN1 seemed to correlate with the 
levels of expansion in different organs (Figure 2.8B). The levels of these proteins were 





Figure 2.8 MMR and BER proteins in indicated organs of FX PM mice. 
Thirty micrograms (30ug) of protein extracted from the brain of one year old 
male  FX PM mice (n=3) were resolved on a gradient Tris-acetate gel, 
electroblotted to nitrocellulose membrane, and probed with the indicated 
antibodies. A) Representative data displaying the amounts of MSH2, MSH3, 
MSH6 proteins in brain, heart, liver, kidney, and testis B) Levels of OGG1, 
NEIL1, APE1, FEN1, DNA ligase 1, DNA ligase 3, Polβ, Polε, and 
Polδ . Equal amount of protein from the organs of each animal were pooled 




2.2.3.1.4 Lack of gender biases in the levels of DNA repair proteins in FX PM mice 
To test whether there are differences in the expression of various DNA repair 
proteins that could explain the gender differences in the level of expansion seen in our 
mouse, we examined in males and females the levels of expression of a number of 
autosomal DNA repair genes previously shown to be involved in expansion in various 
models of some Repeat Expansion Disorders. We also compared the expression levels 
of various DNA repair genes that are located on X chromosome in male and female 
mice. We used Western blotting to compare the amounts of the MMR proteins MSH2, 
MSH3, and MSH6, and the BER proteins OGG1 and NEIL1 in the liver tissues of 4 male 
and 4 female mice. We also measured the protein levels of UBE1, expressed by Ube1 
(ubiquitin-like modifier activating enzyme 1), an X-linked gene that escapes X-
inactivation in mice. Ube1 is a DNA repair gene that catalyzes the first step in ubiquitin 
conjugation to mark cellular proteins for degradation (KUDO et al. 1991). We also 
measured the levels of SMC1a, a protein expressed by Smc1a (structural maintenance 
of chromosomes 1A), another X-linked gene that escapes X inactivation in mice (YANG 
et al. 2010). In all cases,  β actin was used as a loading control. 
No significant difference in the expression of MSH2, MSH3, MSH6, OGG1 and 
NEIL1 proteins were seen in organs of female and male FX PM mice (Figure 2.9). The 
amount of the X-linked DNA repair proteins, UBE1 and SMC1a, were also similar in 
both males and females. Thus, there must be other contributing factors that reduce the 




Figure 2.9 DNA repair protein levels in female and male FX PM mice. Thirty 
micrograms of protein extracted from the liver of one year-old male (n=4) and female 
(n=4) FX PM mice were resolved by electrophoresis on a gradient Tris-acetate gel, 
electroblotted onto nitrocellulose membrane, and probed with the indicated antibodies. 
 β actin was used as loading control. A) Amounts of DNA repair proteins implicated in 
one or more mouse models of the Repeat Expansion Diseases. B) Levels of DNA repair 
genes located on the X chromosome.  
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2.2.3.1.5 Lack of protective effect of estrogen on expansion in FX PM females 
mice 
Estrogen has been shown to protect against oxidative damage (RICHARDSON et 
al. 2012). Since oxidative damage has been shown to increase expansion risk in the FX 
PM mice, we hypothesized that estrogen may decrease the risk of expansion in 
females. To test this idea, we ovariectomized 3 PM females at 16 days old and 
compared the extent of somatic expansion in the tail, brain, kidney, liver, heart, and 
ovary of these mice at 12 months of age to unovariectomized mice of the same age by 
PCR as described in the Material and Methods chapter. We found no differences in any 
organ in the extent of somatic expansion between ovariectomized and 
unoveriectomized FX PM mice (Figure. 2.10). These data suggest that a protective 
effect of estrogen does not explain the lower level of somatic expansion in females. 
 
 
Figure 2.10 Somatic expansion in ovariectomized PM FX female mice. 
Representative Gene Mapper profiles of one-year-old unovariectomized and 
ovariectomized mice with similar repeat numbers. The dotted line and the red 





We have shown that expansion can occur in human somatic cells. We observed 
the stepwise conversion of a PM allele with ~118 repeats to one with 208 repeats i.e., in 
the FM range (Figure 2.2). We have also shown that the degree of somatic expansion of 
the FX PM alleles in different organs of mice is age-dependent, tissue-specific, and 
gender-biased (Figures 2.3, 2.4, and 2.5). Somatic expansion of the FX PM alleles in 
these animals becomes clearly apparent at 4 months of age and increases with age. 
This would be consistent with a mechanism in which somatic expansions accrue by 
incremental increases in repeat number over a period of time, as shown by previously 
published data on somatic expansion in mouse models of other Repeat Expansion 
Diseases (ISHIGURO et al. 2001; VAN DEN BROEK et al. 2002; GONITEL et al. 2008). 
 In the FX PM mouse model organs such as brain, liver, and gonads were more 
prone to expand than kidney, with the PM allele being stable in heart. The highest level 
of expansion is seen in the brain and liver, where most of the cells are post-mitotic. This 
supports the hypothesis that expansion is not dependent on chromosomal replication. 
This is consistent with work by others in the Usdin laboratory showing that expansion 
occurs in oocytes, which do not divide. It is also consistent with an observed maternal 
age-effect on the expansion risk in humans (YRIGOLLEN et al. 2012). Thus, our data 
lends support to the idea that expansion in FX PM mouse model, and in human PM 
carriers, may be more likely to result from aberrant DNA damage repair than events 
occurring during normal genomic replication. 
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The strong tissue-specificity of expansion that is seen in the FX PM mouse, as 
well as in a number of mouse models of other Repeat Expansion Diseases, has led to 
the suggestion that tissue-specific factors may be involved (LIA et al. 1998; FORTUNE et 
al. 2000). However, not all organs expand to the same extent in mouse models of 
different Repeat Expansion Diseases. For example, while organs like the kidney show 
relatively little expansion in the FX PM mouse model, this organ shows extensive 
expansion in other mouse models (FORTUNE et al. 2000; VAN DEN BROEK et al. 2007). 
Variations in the levels of DNA repair proteins have been suggested to account 
for the tissue-specificity of repeat expansion in mouse models of HD and DM1(GOULA et 
al. 2009; TOME et al. 2013; MASON et al. 2014). For example, in HD it has been reported 
that the levels of BER and MMR proteins correlate with increased somatic CAG 
instability (GOULA et al. 2009; SERIOLA et al. 2011). However, the levels of these proteins 
were examined only in a few sub-regions of the brain or a few cell lines. When we 
examined a wider range of different organs of the FX PM mouse and compared the 
levels of a much larger set of proteins, no good correlation between the extent of 
expansion and the levels of any of the previously identified proteins. However, while 
neither the level of MSH2 or the level of MSH3 correlated well with the extent of 
expansion in all organs, the combination of MSH2, MSH3 and MSH6 did have a 
correlation (Figure 2.8A). In addition, the levels of APE1 and FEN1 also showed a 
correlation (Figure 2.8B).  
We also showed that somatic expansion of the FX PM is more extensive in 
males than females, while the organs prone to expand remained the same in both 
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genders (Figures 2.4 and 2.5). We found that this gender difference was due in part to 
the fact that Fmr1 is an X-linked gene and that expansion occurred only on a PM allele 
that was located on the active X chromosome (Figure 2.6). This observation suggests 
that transcriptional activity of the gene or an open chromatin configuration is necessary 
for the expansion to occur. These data support previous observation that in human 
carriers of methylated FM alleles, the repeat is stable (GLASER et al. 1999). It also lends 
support to previous suggestions that transcription plays a role in repeat expansion in 
mouse models of HD and DM1(LIA et al. 1998; GOULA et al. 2012). However, since 
chromosomal context affects expansion and the chromosomal context of the transgenes 
being compared in these cases differed from one another, it was not possible to 
definitively implicate transcription/open chromatin in expansion based on these 
experiments. But, since Fmr1 is an X-linked gene, we were able to compare 
simultaneously the extent of expansion of the same PM allele in the same sequence 
context on the active and inactive X chromosome in the same animal. Thus, our data 
allowed us to definitively demonstrate a requirement for transcription and/or an open 
chromatin configuration in the FX expansion in mice. Our data are also consistent with a 
retrospective examination of data from human females who carry the PM allele (GRASSO 
et al. 2014). 
However, as was shown by others in the Usdin laboratory, there is no good 
correlation between the level of Fmr1 expression in expansion prone organs and the 
degree of somatic expansion in the same organs (LOKANGA et al. 2013). Furthermore, 
there was no gender bias in the transcription of the Fmr1 gene that could explain the 
gender differences on somatic expansions that is seen in this mouse model (LOKANGA et 
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al. 2013; ZHAO AND USDIN 2014). Therefore, there must be additional unknown factors 
that are necessary for expansion. 
We have analyzed a number of additional potential factors that could contribute 
to the gender differences on somatic expansion in the FX PM mouse, including the 
effect of estrogen and differences in the expression of a number of DNA repair genes 
known to be important for expansion (Figures 2.9 and 2.10). However, none of these 
factors are likely contributors to the gender difference seen on somatic expansions in 
our mouse model either. Data generated by others in the Usdin laboratory have shown 
that many genes involved in the removal of damaging reactive oxygen species (ROS) 
are highly expressed in female than male FX PM mice. Since we know that oxidative 
stress increases expansion risk (ENTEZAM et al. 2010), it is possible that these gender 
differences in the sensitivity to oxidative stress contribute to the gender biases on 
somatic expansion that we have observed. 
In summary, we have shown that somatic expansion of FX PM alleles occurs in 
both human cells and in mice. In mice, somatic expansion is age-dependent, variable in 
different tissues, and occurs more frequently in males than females. Since disease 
symptoms are related to repeat number in humans, it is possible that somatic expansion 
contributes to disease risk and that identifying factors that reduce somatic expansion 
can be clinically useful. Furthermore, since somatic expansion is less frequent in PM 
female mice, it might also suggest that human females who are carriers of PM alleles 
may have lower risk for somatic expansion than human males.  
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Chapter 3:  Effect of a null mutation in the MMR genes, Msh2 




The Fragile X related disorders are caused by the expansion of a CGG•CCG 
repeat tract in the 5’ UTR of the FMR1 gene. We have shown in the previous chapter 
that somatic expansion of the FX PM alleles occurs in human cells and in the FX PM 
mouse and that this expansion is tissue-specific with brain, liver and testes being more 
prone to expand than the kidney and heart. However, the molecular basis of FX PM 
repeat expansion and the factors that can explain the tissue specificity of expansion in 
the FX PM mouse model are not well understood. 
The role of the mismatch repair (MMR) system in repeat expansion has been 
studied in a number of mouse models of various Repeat Expansion Disorders. 
However, the effects of MMR deficiency on the frequency of somatic and/or germ-line 
repeat expansions in these diseases were variable. For instance, in the mouse model of 
DM1, null mutations in Msh2 gene, the key enzyme of the MMR pathway, resulted in 
suppression of somatic expansion and of most paternally and maternally transmitted 
expansions (SAVOURET et al. 2003). Furthermore, an Msh2 null mutation was also 
shown to prevent somatic expansion (MANLEY et al. 1999a) and to abolish paternally 
transmitted but not maternally transmitted expansions in the mouse model of HD 
(WHEELER et al. 2003). However, in a transgenic mouse model of FRDA, an Msh2 null 
mutation failed to reduce intergenerational expansion (EZZATIZADEH et al. 2012). 
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Studies of MSH3 and MSH6, the two MSH2-binding partners in mammalian cells, 
also resulted in variable outcomes. In a DM1 knock-in mouse model, an Msh3 null 
mutation abolished somatic expansions whereas an Msh6 null mutation increased 
somatic expansions (VAN DEN BROEK et al. 2002). In a transgenic mouse model of this 
same disease, MSH3, but not MSH6, was shown to be involved in germ line repeat 
expansion (FOIRY et al. 2006). In a mouse model of HD, a null mutation of Msh3 did not 
have significant effect on intergenerational repeat expansion, but eliminated somatic 
expansions (DRAGILEVA et al. 2009). While MSH6 was shown not to be involved in the 
repeat expansions, it was shown instead to protected against parental intergenerational 
repeat contractions (DRAGILEVA et al. 2009). In contrast, in a transgenic mouse model of 
FRDA MSH6 was shown to be involved in the formation of GAA repeat somatic 
expansions (BOURN et al. 2012). Additionally, work in FRDA patient cells also supports a 
role for MSH6 in somatic expansions (DU et al. 2012). Thus, FRDA is the only Repeat 
Expansion Disease for which published data implicates MSH6 in the generation of 
repeat expansions.  
Thus, the effects of the mismatch repair proteins on repeat instability appears to 
differ in different Repeat Expansion Diseases and in some cases to vary between germ 
line and somatic cells. This may indicate that different mechanisms are involved in 
expansion in different diseases and in different cell types. In an effort to better 
understand the mechanism of repeat expansion in the FXDs as well as factors that can 
explain the tissue specificity seen in the FX PM mouse model, we investigated the 
potential role of MSH2 and MSH6 in repeat expansion in the FXD mouse model. It 
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should be noted that the role of MSH3 in this mouse has been studied (ZHAO et al. 
2015).  
3.2 Results: 
3.2.1 Somatic expansion of the FX PM alleles is reduced in MSH2 or MSH6 
deficient mice.  
To investigate whether the MSH2 and MSH6 proteins promote or prevent 
somatic expansion in FX PM mice, we analyzed somatic instability in multiple organs 
from WT mice of same age, gender and repeat number that were heterozygous or 
nullizygous for either Msh2 or Msh6. We first crossed the FX PM mice to mice that have 
a null mutation in either Msh2 or Msh6 in order to generate mice that have the PM allele 
and that are heterozygous or nullizygous for either Msh2 or Msh6. Since Msh2 and 
Msh6 null mutations predispose these mice to cancer and thus these animals die 
young, we primarily assessed somatic instability in mice that were less than 12 months 
old. However, 3 Msh6 null female mice survived to twelve months of age and somatic 
instability was assessed in these animals as well. 
We isolated genomic DNA from tail, brain, kidney, liver, heart, and gonads of 
mice for somatic instability analysis in Msh2 and Msh6 mutant mice as described in the 
Materials and Methods chapter. With the exception of the 12-month-old Msh6-/- mice 
where only 3 animals were available, we analyzed 6 animals per genotype. The 
genomic DNA was amplified by PCR using the primer pair Frax m5 and Frax m4, where 
Frax m4 was fluorescently labeled with either 6-carboxyfluorescein (FAM) or 4, 7, 2′, 4′, 
5′, 7′-hexachloro-6-carboxyfluorescein (HEX). The choice of the fluorescent label does 
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not affect the results in any way (per our observation). The PCR product was then 
resolved on an ABI 3130XL Genetic Analyzer and the data analyzed using GeneMapper 
4.0 software, as detailed in the Materials and Methods chapter.  
The effect of Msh2 or Msh6 mutations on somatic expansion was determined by 
comparing the number of CGG•CCG repeats in the DNA from different organs at time of 
death to the repeat number found in the tail DNA of the same animal at three weeks of 
age (tail 1). We also quantitated the extent of somatic expansion using the somatic 
instability index (SII) as described in the Materials and Methods chapter (LEE et al. 
2010). We then compared the degree of somatic instability in animals that were WT, 
heterozygous or nullizygous for either Msh2 or Msh6. 
3.2.1.1 Somatic expansion is eliminated in MSH2 deficient mice. 
Analysis of 4 and 6 month old Msh2+/+ (WT) mice showed evidence of somatic 
expansion in most organs consistent with our previous findings that somatic expansion 
is progressive and tissue specific (Chapter 2). In contrast, analysis of Msh2−/− mice 
showed no evidence of somatic expansion in any of the organs examined in either 4 or 
6 month old mice as evidenced by the fact that the GeneMapper profiles for organs that 
are expansion prone in Msh2+/+animals are indistinguishable from organs like heart that 
show no somatic expansion and similar to the profile generated from tail DNA taken 
soon after birth (Figure. 3.1A). This was consistent with the fact that all tissues had 





Figure 3.1 Somatic expansion in MSH2 deficient mice. (A) Representative 
GeneMapper scan showing expansion in indicated organs of a 6-month-old Msh2+/+ and 
a 6-month-old Msh2−/− mouse. The dotted line indicates the original allele size in tail 1 (3 
weeks). (B) Average somatic instability index (SII) in different organs of Msh2+/+ (n=6) 
and Msh2−/− (n=6) mice at 4 and 6 months of age. 
 
The slight negative values of the SII do not indicate an increase in somatic 
contraction since the SII does not change with age and it resembles at both ages the SII 
of heart, an organ that shows no expansions or contractions in WT animals. The low 
negative values of SII likely reflect the presence of stutter bands, PCR artifacts 
produced during PCR amplification of short tandem repeats (WALSH et al. 1996). Our 
data thus suggest that MSH2 is essential for somatic expansion in FX mice. 
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We also analyzed somatic expansion in brain, liver and testes of Msh2+/− mice at 
12 months of age since Msh2 heterozygous mice lived longer than Msh2 null animals. 
We found that even the loss of one Msh2 allele was sufficient to reduce significantly 
somatic expansion in most organs (Figure 3.2A). The average repeat number added in 
the brain, liver, and testis of Msh2+/+ mice was 9.5, 20.5, and 12.5 respectively, and 4.2, 
11.8, and 9.9 in Msh2+/− mice. While the difference in repeats size in the brain and liver 
of Msh2+/+ versus Msh2+/− mice was statistically significant, the difference in repeat size 
in the testis of Msh2+/+ versus Msh2+/− mice did not reach the preset statistical 
significance of p<0.05 (Figure 3.2B). Though, the SII was significantly reduced in all 
organs of Msh2 null animals, no allele smaller than the original allele (tail 1 or heart) 
was observed in any organ and at any age. Thus, there was no evidence of increased 





Figure 3.2 Expansion in the indicated organs of Msh2 heterozygous FX PM mice. 
(A) Representative overlaid GeneMapper scans showing expansion in a one-year-old 
Msh2+/+ and a one-year-old Msh2+/− mouse. The dotted line shows the parental inherited 
allele size in tail 1 (3 weeks). (B) The average repeat number added to the original allele 
in indicated organs of 6 Msh2+/+ and 6 Msh2+/− male mice. The error bars indicate the 
standard deviation. The asterisks indicate organs with significantly different numbers of 




3.2.1.2 Somatic expansion is reduced in MSH6 deficient mice 
In mammalian cells, MSH2 forms a heterodimer with either MSH6 or MSH3 to 
form MutSα and MutSβ complexes respectively (KOLODNER 1996; KOLODNER AND 
MARSISCHKY 1999; KUNKEL AND ERIE 2005; LI 2008). In order to see whether MutSα is 
involved in FX PM repeat expansion, we examined the effect of the Msh6 null mutation 
on somatic expansion in FX PM mice. We examined repeat expansion in somatic cells 
of 6 Msh6−/− male mice at 6 month of age. Since we have shown in the previous chapter 
that somatic expansion is age dependent and less frequent in female than in male FX 
PM mice, we limited somatic instability analysis in female mice to the 3 animals that 
survived to 12 months of age.  
Analysis of the data from the six 6-month-old male mice showed that the loss of 
MSH6 significantly reduced the extent of somatic expansion in all expansion-prone 
organs (Figure 3.3). While the repeat size in heart was stable in both Msh6+/+ and in 
Msh6−/− mice, expansion was considerably reduced in the tail, liver, and testis (p< 
0.0001) and in brain (p< 0.001) of Msh6−/− mice. The SII in the tail, brain, liver, and 
testis were 1.1, 4.0, 3.3 and 1.6 respectively in Msh6−/− mice and 6.0, 6.0, 8.0, and 9.2 
in Msh6+/+ mice. Taken together these data suggest that MSH6, and thus MutSα, 
contributes either directly or indirectly to expansion of the FX PM alleles. However, the 
effect of the loss of MSH6 is not as severe as the loss of MSH2 (this chapter) or the loss 







Figure 3.3 Expansion as measured by the SII in indicated organs of Msh6+/+ and 
Msh6-/- male FX PM mice. The data represents an average of 6 Msh6+/+ and 6 Msh6−/− 
animals at 6 months of age. The organs marked with asterisks represent those with 
statistically different SIIs by Student’s t-test (*p < 0.01 ** p< 0.001, and *** p< 0.0001). 
 
Analysis of GeneMapper scans of one year-old female Msh6+/+ mice showed a 
moderate level of somatic expansion in all expansion prone organs including brain, liver 
and ovaries consistent with our previous data that showed that somatic expansion in 
female mice occurs less frequently than in males (Chapter 2). In contrast, analysis of 
GeneMapper profile of Msh6−/− mice revealed that the extent of somatic expansion was 
significantly reduced in the tail taken at time of euthanasia (p=0.001) and in the ovaries 
(p< 0.001) of Msh6−/− mice with the SII of 2.5 in tail and 0.59 in ovary compared to 5.9 
and 2.75 in tail and ovary of Msh6+/+ mice respectively (Figure 3.4). However, the 
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difference in the SII of the brain, liver, and kidney was not statistically significant 
between Msh6+/+ and Msh6−/− mice. As in Msh2−/− mice, no allele smaller than the 
original allele was seen in any organs of either female or male Msh6−/− mice, confirming 
that somatic contraction does not occur or is rare in FX PM mice.  
 
Figure 3.4 Expansion as assessed by the SII in indicated organs of Msh6+/+ and 
Msh6-/- female FX PM mice. Four Msh6+/+ and 3 Msh6−/− females were analyzed at 12 
months of age. The asterisks indicate the organs in which the loss of MSH6 had a 




3.2.2 Germ line expansion of FX PM alleles is reduced in MSH2 and MSH6 
deficient mice.  
In order to evaluate the role of MSH2 and MSH6 on the intergenerational 
instability of the CGG•CCG repeat, we crossed mice that had one PM allele and were 
heterozygous or nullizygous for either Msh2 or Msh6 to mice that had a wild type Fmr1 
allele and the same Msh2 or Msh6 genotype as detailed in the Materials and Methods 
section. We then evaluated the frequency of expansion, contraction, and unchanged 
alleles in the offspring of these mice. For each genotype at least three breeding pairs 
were set up. We followed instability on both maternal and paternal transmission. Since 
Msh2 and Msh6 null mutations predispose these mice to cancer and thus these animals 
die young, we only assessed intergenerational instability in mice less than 12 months 
old. 
Genomic DNA was extracted from tail biopsies of the animals at weaning. 
Amplification of the FX PM repeats and repeat size analysis were carried out as 
described in the Materials and Methods chapter. Intergenerational instability was 
determined by comparing the repeat size in the transmitting parent with that of the 
progeny to determine the frequency of expansion, contraction, and unchanged alleles 
(Figure 3.5). The parental and offspring PCR amplicons were resolved at the same time 





Figure 3.5 Example of GeneMapper profiles analysis. GeneMapper profiles 
illustrating intergenerational CGG•CCG repeat instability in FX PM mouse model .The 
first profile is the profile generated from the tail DNA of the parent, while the remaining 
profiles are profiles generated from the tail DNA of 3 of its offspring. The first pup has 
the same repeat number as the transmitting parent, thus the allele is scored as 
unchanged. The second pup has fewer repeats than the parent; therefore, it has 
undergone contraction. The last pup has more repeats than the parent. Thus this pup 
has inherited an expansion. Numbers above the GeneMapper profile corresponds to the 





3.2.2.1 Intergenerational expansion is eliminated in MSH2 deficient mice  
Analysis of offspring derived from Msh2+/+ parents revealed that the frequency of 
expansions in the progeny was 96% when the PM allele was paternally transmitted and 
62% when the allele was maternally transmitted (Figure 3.6). In the progeny of Msh2+/− 
mice the frequency of expansion was significantly reduced, to 72% for paternally 
transmitted alleles and to 38% when the allele was transmitted maternally. 
 
 
Figure 3.6 Effect of MSH2 deficiency on intergenerational instability. The 
frequency of expansions, contractions and unchanged alleles in the progeny of Msh2+/+, 
Msh2+/−,and Msh2−/− in FX PM mice. The numbers of animals analyzed in each category 
are shown above each bar.  
The average size of the expansion in the progeny of Msh2+/− mice on paternal 
transmission was 5.5 repeats compared to 7.7 repeats in the progeny of Msh2+/+ mice 
(p<=0.009) by t test. There was no statistically significant difference in the average 
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expansion size when the PM allele was maternally transmitted in Msh2+/+ and Msh2+/− 
animals (3.2 compared to 3.0 repeats, p= 0.762 by t test (Figure 3.6).  
The progeny of Msh2−/− mice showed no evidence of expansion on either 
maternal or paternal transmission of the PM allele. This loss of expansions was 
associated with an increase in alleles that had undergone contractions (40%) and 
alleles that were left unchanged (60%). These data suggest that MSH2 protein is 
essential and required for intergenerational repeat expansion of the PM alleles in the FX 
PM mice. Furthermore, the fact that in the progeny of Msh2−/− mice the number of 
contractions was increased, suggests that either that MSH2 is not necessary for 
intergenerational repeat contractions or that there is more than one contraction 
mechanism. Work by others in the Usdin laboratory suggest the latter, and that in the 
FX PM mouse model two contraction mechanisms exist one that requires MutSβ and 





Figure 3.7 The profile of repeat size variations on intergenerational transmission 
in Msh2+/+, Msh2+/−, Msh2−/− mice. Graph showing the percentage of alleles with the 




While no expansions were seen in the Msh2−/− progeny of Msh2−/− parents, 
Msh2−/− pups from Msh2+/− parents had a similar expansion frequency as their Msh2+/+ 
littermates (Table 3.1). These data suggest that the expansion frequencies in the FX 
PM mice are dependent on the gene dosage of the transmitting parent instead of the 
offspring gene dosage.  


















+/+ +/+ 99 64 15 21 
+/- 
+/+ 25 48§ 28 24 
+/- 56 43§ 32 25 
-/- 19 37§ 26 37 
-/- -/- 58 0 52 48 
male 
+/+ +/+ 115 96 0 4 
+/- 
+/+ 12 75§ 8 17 
+/- 21 67§ 5 28 
-/- 9 78§ 0 22 
-/- -/- 45 0 40 60 
 *Parents in each case had the same Msh2 genotype, but only one had the PM allele. § Data not 
statistically significantly different  
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3.2.2.2 Intergenerational expansion is also reduced in MSH6 deficient mice  
Having shown that in the absence of MSH2 all expansions are abolished in the 
FX PM mice; we then investigated whether MSH6, the partner of MSH2 in the MutSα 
complex involved in the repair of single-base mismatches, also played a role in 
intergenerational expansions. We found that the frequency of intergenerational 
expansions was significantly reduced in the progeny of Msh6-/- mice (Figure 3.8). On 
paternal transmission in Msh6-/- animals, we observed a lower frequency of expansion, 
35% compared to 81% on transmission from Msh6+/+ males (p<0.001). A higher 
frequency of contractions, 30% compared to 7% in Msh6+/+ transmissions (p<0.001), 
was also seen. Similar results were seen for Msh6-/- maternal transmissions. The 
expansion frequency was 42% versus 85% in Msh6+/+ animals (p<000.1) and the 
contraction frequency was 30% versus 8% in the progeny of Msh6+/+ animals (p<0.001). 
We also observed an increase in the frequency of unchanged alleles in the Msh6-/- 
mice. 
In contrast to what was seen in Msh2 heterozygous mice, where the loss of one 
single functional Msh2 allele significantly reduced the frequency of expansion, analysis 
of intergenerational instability in the progeny of Msh6+/− mice showed that the loss of 





Figure 3.8 Effect of MSH6 deficiency on intergenerational instability. The 
frequency of expansions, contractions and unchanged alleles in the progeny of Msh6+/+, 
Msh6+/−,and Msh6−/− FX PM mice. The number above each bar represents the number 
of animals analyzed in each category. 
 
The loss of MSH6 also significantly reduced the average number of repeats 
added (2.5 versus 5.7 repeats; p<0.001) on Msh6-/- paternal transmissions (Figure 3.9). 
In the progeny of Msh6-/- mothers the average number of repeats added was also 
reduced compared to Msh6+/+ mothers, however, the difference was not statistically 
significant due to high standard deviation in WT samples (3.0 versus 5.5 repeats in 
Msh6+/+ transmission; p=0.096). The repeat size was not reduced in the progeny of 
Msh6+/− mice on either paternal or maternal transmissions. Thus our data suggests that 






Figure 3.9 The profile of repeat size variations on intergenerational transmission 
in Msh6+/+, Msh6+/−, Msh6−/− mice.  Graph showing the percentage of alleles with the 




To ascertain whether the reduced expansion frequency seen in different organs 
of Msh6−/− mice and on intergenerational transmission was an indirect effect of reduced 
levels of MSH3 in Msh6 null mice as was suggested for in the DM1 transgenic mouse 
model on a mixed C57BL/6 x 129/OLA/FVB genetic background (FOIRY et al. 2006), we 
compared the levels of MSH2 and MSH3 in the ovary of Msh6+/+ and Msh6−/− mice 
using Western blots. We found that, as expected, the level of MSH2 is reduced in the 
ovaries of Msh6−/− mice compared to Msh6+/+ mice. This is consistent with the idea that 
the loss of MSH6 results in proteolytic degradation of the MSH2 normally bound to it. 
However, we did not find any significant differences in the level of MSH3 in Msh6+/+ and 
Msh6−/− mice (Figure 3.10). Similar results for the levels of MSH3 were obtained in the 
brains of Msh6+/+ and Msh6−/− of female mice using an ELISA assay (Table 3.2). 
However, the assay was not sensitive enough to use to verify the Western blot data for 
the MSH3 levels in ovary. Data generated by others in the laboratory showed that 
MSH3 is also not reduced in many other tissues of Msh6−/− male mice including brain, 
liver and testes, suggesting that the reduced expansion seen in the Msh6−/− FX PM 




Figure 3.10 MSH2 and MSH3 protein levels in the ovaries of Msh3 and Msh6 null 
mice. (A) Western blot showing MSH2 and MSH3 levels in ovary (B) Relative amount of 
MSH2, and MSH3 in ovary of Msh6+/+, Msh3-/- and Msh6-/- mice. Beta actin was used as 
protein loading control. In ovary, a doublet was observed for MSH3 that may indicate 






Table 3.2 MSH3 protein levels in the brain of Msh6 null and Msh6 WT mice 
 
 
Msh6+/+  Msh6-/- 
 
Mouse 1 Mouse 2 Mouse 3 Mouse 1 Mouse 2 Mouse 3 
Replicate 1 5.930 3.804 4.850 5.510 4.170 4.690 
Replicate 2 5.920 3.550 4.990 5.620 4.260 4.880 
Average  (pg/ml) 5.925 3.677 4.920 5.565 4.215 4.7850 
 Average (pg/ml) SD Average (pg/ml) SD 




To investigate the molecular mechanism involved in FX PM repeat instability in 
the FXDs, the effects of the MMR proteins MSH2 and MSH6 were examined in adult 
somatic tissues and during intergenerational transmission of the FX PM repeats. We 
report here that no evidence of expansion was seen at any age in any organ of Msh2-/- 
mice (Figure 3.1) or in any offspring of Msh2-/- mice regardless of the gender of the 
transmitting parent (Figure 3.6). Our data thus demonstrate that MSH2 is absolutely 
necessary for all CGG•CCG repeat expansions in the FX PM mice. Thus, our results 
differ from those seen in some other Repeat Expansion Disorders, where the loss of 
MSH2 had an effect on expansion frequency ranging from 0-96% depending on the 
sequence of the repeat and the gender of the transmitting parents (MANLEY et al. 1999b; 
KOVTUN AND MCMURRAY 2001; SAVOURET et al. 2003; WHEELER et al. 2003; DRAGILEVA 
et al. 2009; EZZATIZADEH et al. 2012). Furthermore, while all expanded alleles were 
replaced by unchanged and contracted alleles at similar frequencies in the FXDs, in 
other Repeat Expansion Disorders such DM1 where all expansions were replaced by 
contractions (~90%) (SAVOURET et al. 2003). Thus, our data reinforce the idea of how 
variable the effect of MMR components can be in different Repeat Expansion Disorders 
 We have also shown that the loss of a single functional Msh2 allele significantly 
impacts both somatic and intergenerational expansions. The average expansion size in 
the most expansion prone tissues like brain and liver decreased significantly. However, 
in the testis, one of the other expansion prone tissues, the effect of loss of one Msh2 
allele was not statistically significant (Figure 3.2). We have shown in Chapter 2 that 
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MSH2 was more abundant in the testis than in the brain and liver (Figure 2.8). One 
explanation of our Msh2+/- data could be that in Msh2+/− mice, the MSH2 protein is rate 
limiting in brain and liver, but not in testis. Therefore, the difference in the repeat 
number added in Msh2+/+ versus in Msh2+/− may suggest that the frequency at which 
expansion is occurring in the somatic cells is dependent on the levels of MSH2. As in 
somatic tissues, the loss of one functional Msh2 allele resulted in a reduced frequency 
of expansion on both maternal and paternal transmissions (Figure 3.6). This is different 
from what is seen in the mouse model of CAG repeat expansion where loss of one 
Msh2 allele did not reduce significantly the frequency of expansion in paternal 
transmissions (DRAGILEVA et al. 2009).  
While no expansion was seen in any Msh2−/− progeny from Msh2−/− parents, a 
similar frequency of expansions was seen in the Msh2−/− progeny of Msh2+/− parents as 
their Msh2+/+ or Msh2+/− littermates (Table 3.1). These data suggest that expansion 
frequencies may be sensitive to the gene dosage in the transmitting parent rather than 
in the offspring gene dosage. This would be consistent with previous evidence in the 
laboratory that expansions occur in the oocyte, a finding that is consistent with what has 
been proposed for humans (MALTER et al. 1997) and what can be inferred from the 
effect of maternal age on expansion risk in women (YRIGOLLEN et al. 2014)  
Our data, thus, show that MSH2 is absolutely required for expansion in the FX PM mice. 
Furthermore, data obtained by others in the Usdin laboratory have shown that MSH3, 
the binding partner of MSH2 in MutSβ complex, is also required for all somatic 
expansions and more than 98% of germ line expansion in the FX PM mice (ZHAO et al. 
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2015). Taken together, our data suggest that the MutSβ complex is the major promoter 
of repeat expansions in the FXDs mice. However, my data shown here also 
demonstrates that MSH6 (therefore, MutSα ) contributes significantly to both somatic 
and intergenerational expansions in the FX PM mice (Figures 3.3, 3.4, 3.8 and 3.9). I 
showed that this effect is not an indirect one resulting from changes in the levels of 
MSH3 protein in Msh6-/- mice (Figures 3.10, table 3.2). Moreover, while MutSα  and 
MutSβ complexes do have some overlapping roles in the MMR pathway, it has been 
reported that loss of MSH6, thus, MutSα in mouse or in human cells does not affect the 
repair of MutSβ substrates (EDELMANN et al. 1997; OHZEKI et al. 1997; YANG et al. 2004; 
TSENG-ROGENSKI et al. 2012; CARETHERS et al. 2015). Thus, redeployment of MutSβ to 
damage sites normally repaired by MutSα is unlikely to account for the decrease in the 
intergenerational and somatic expansions seen in Msh6-/- mice. Thus, our data likely 
reflect a direct contribution of MutSα  to the expansion process in the FX PM mice. This 
makes the FX PM mouse model the only Repeat Expansion Disease mouse model 
where MutSα has been found to promote both germ line and somatic expansions.  
A role for MutSα in promoting repeat expansions is consistent with our previous 
observations in Chapter 2 that while MutSβ levels alone do not correlate well with the 
levels of somatic instability across the 5 different organs examined, a better correlation 
is seen when the levels of both MutSα and MutSβ are considered. However, since in 
the FX PM mouse almost all expansions are lost in the absence of MSH3 (ZHAO et al. 
2015), MutSα must be somehow working in concert with MutSβ to generate repeat 
expansion in the FX PM mice. Work by others in the Usdin laboratory have 
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demonstrated that MutSα is able to stabilize the hairpins formed by the FX repeats that 
are thought to be the substrates for expansion (ZHAO et al. 2015). It may be that when 
MutSβ is rate limiting, that MutSα increases the half-life of the hairpins and prevents 
their removal by another repair mechanism, preserving them for later processing by 
MutSβ into expansions. It may be that the effect of MutSα is only apparent when the 
amount of the expansion substrate exceeds the ability of MutSβ to process them 
immediately.This  could explain our observation that loss of MSH6 had a larger effect on 
somatic expansion in males than in females (Figures 3.3 and 3.4), since while MMR 
protein levels are very similar in males and females, males have higher expansion 
frequency (Chapter 2, Figure 2.4).  
Since Msh6-/- animals (Figure 3.8), but not Msh3-/- animals (ZHAO et al. 2015), 
also show an increase in the contraction frequency, MutSα is also involved in protecting 
the genome against intergenerational contractions. Similar protective effects of MutSα 
against repeat contraction were reported in the mouse model of FRDA (EZZATIZADEH et 
al. 2012). The role of MutSα in protecting against contractions might be consistent with 
a classical MMR process, except that in this case the repair is triggered by an atypical 
repair substrate. Thus, our data suggest that MutSα participates in two different 









We have shown in the previous chapter that the MMR pathway is important for 
the expansion process in the FX PM mice. However, the mechanism by which the MMR 
pathway promotes repeat expansion remains unknown. Previous work in the Usdin 
laboratory that I was involved with prior to beginning my thesis, showed that treating FX 
PM mice with potassium bromate, a strong oxidizing agent, increases intergenerational 
repeat expansion (ENTEZAM et al. 2010). This raises the possibility that Base Excision 
Repair (BER), the major pathway involved in oxidative damage repair of DNA may also 
contribute to expansion. Since BER proteins are recruited to regions of open chromatin 
in response to oxidative stress (AMOUROUX et al. 2010), a role for BER in expansion 
might also explain why open chromatin is necessary for expansion as I demonstrated in 
Chapter 2. Previous work had demonstrated that the loss of OGG1 or NEIL1, two 
glycosylases that initiates BER, reduced somatic expansion in a mouse model of HD 
(KOVTUN et al. 2007; MOLLERSEN et al. 2012). However, loss of these proteins did not 
affect the frequency of germ line expansion. While it is possible that other DNA 
glycosylases may be more important for BER in the germ line, it was also possible that 
BER was not essential for expansion, but that nicks generated by BER DNA 
glycosylases, along with nicks generated by other enzymes, could be used by MMR 
proteins to subsequently generate expansions, perhaps by a form of non-canonical 
MMR repair (PENA-DIAZ et al. 2012).  
In an effort to understand the mechanism of repeat expansion in the FXDs, we 
investigated the effect of an Y265C mutation in DNA polymerase beta (Polβ) on the 
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extent of expansion in somatic tissues and in sperm of FX PM mice. Polβ is a ~39kDa 
protein that belongs to X family of DNA polymerases that is essential for BER (LOEB AND 
MONNAT 2008) . Polβ possesses a 5'-deoxyribose-5-phosphate lyase activity that can 
remove native sugar phosphate residues generated by base excision. It is also able to 
carry out DNA synthesis to accomplish single nucleotide BER (BEARD AND WILSON 2006; 
LIU AND WILSON 2012). Polβ can also perform multi-nucleotide gap-filling and strand 
displacement synthesis that can result in an inefficient long-patch BER if the short patch 
is not efficiently completed due to oxidation or reduction of the deoxyribose 5-phosphate 
group (LIU AND WILSON 2012). It has been suggested that Polβ multi-nucleotide gap-
filling synthesis can promote both expansion and deletion of the CAG repeat (LIU et al. 
2009). Thus, this enzyme may play an essential role in modulating repeat instability. 
The Y265C mutation is a dominant Polβ mutation found in humans that results in 
a hypomorphic Polβ variant with a slow DNA polymerase activity and a lower fidelity 
(SENEJANI et al. 2012). In order to investigate the role of Polβ deficiency on FX repeat 
expansion, we examined somatic and germ line instability in the sperm of mice in which 
the normal mouse PolB gene was replaced with one carrying the Y265C mutation 






It had been reported that approximately 40% of PolB homozygous mutant mice 
(PolBc/c) survive past birth. However, in our hands we were unable to generate any 
viable homozygous mutant mice in a pure C57BL/6 background and in animals 
backcrossed for 4 generations onto a 129S1 background. Consequently, we limited our 
research to heterozygous (PolB+/c) animals only.  We assessed somatic instability in 
mice at 16 months of age and germ line instability in the sperm of 3 and 11 month old 
animals. 
4.2.1  Somatic instability is reduced in mice with a Y265C mutation in Polβ . 
In order examine the role of Polβ Y265C mutation on somatic expansion, we first 
generated mice that carried the PM allele and that were heterozygous for the Y265C 
mutation by crossing our FX PM mice to mice with Y265C mutant mice. We then 
evaluated the degree of expansion in different tissues of 16-month-old PolB+/+ and 
PolB+/C males with ~140 repeats in their Fmr1 gene. The genomic DNA from tail, brain, 
kidney, liver, heart, testes was amplified by fluorescent PCR, resolved on a 3130XL 
Genetic Analyzer and analyzed using GeneMapper 4.0 software, as detailed in the 
Materials and Methods chapter. Somatic expansion was analyzed by comparing the 
repeat PCR profile of each organ to the repeat profile seen in the tail DNA of the same 
animal at three weeks of age (tail 1) and by quantifying the amount of somatic 
expansion using the somatic instability index (SII), a quantitative analysis of the degree 
of somatic instability developed in the Wheeler laboratory (LEE et al. 2010). 
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Analysis of the data from three 16 month-old-male PolB+/+ and three 16 month 
old PolB+/C mice revealed that heterozygosity for the PolB Y265C mutation significantly 
reduced the extent of somatic expansion in some expansion prone tissues (Figure 4.1). 
While the repeat was stable in the heart of both PolB+/+ and PolB+/C mice, consistent 
with our previous findings described in chapters 2 and 3, the extent of expansion was 
significantly reduced in the tail (p=0.013) and in the testes (p=0.0011) of PolB+/C mice. 
We also observed a slight decrease in the extent of somatic expansion in the kidney. 
However, this decrease was not statistically significant (p= 0.07). No difference was 
seen between SII values in the liver or brain of PolB+/+ and PolB+/C mice. Since we have 
shown in chapters 2 and 3 that somatic contractions do not occur in the mouse model of 
FX PM, the reduced SII seen in the tail and testes of PolB Y265C mutant mice is 
consistent with a role of Polβ in promoting somatic expansions in our mouse model. The 
fact that heterozygosity for the PolB mutation affects expansion in only a few tissues 
would be consistent with the observation that loss of one copy of PolB does not affect 
mutation rates in most tissues, maybe because some cells have regulatory mechanisms 








Figure 4.1 Expansion as assessed by the SII in indicated organs of PolB+/+ and 
PolB+/C in male FX PM mice. The average somatic instability index (LEE et al. 2010) for 
the indicated organs. WT (black bars) n= 3 PolB+/+ and PolB+/C n= 3 (white bars) at 16 




4.2.2 Germline expansion is also reduced in mice with a Y265C mutation in 
Polβ  
In order to examine the role of PolB Y265C mutation on germ line instability, we 
used small pool PCR of sperm DNA in 3 and 11 month old heterozygous males carrying 
the PM. We isolated the genomic DNA from sperm as described in the Materials and 
Methods chapter and carried out small pool PCR on these DNAs using a nested PCR 
strategy. The first round of PCR was carried out with ~ 3pg of genomic DNA as 
template, the equivalent of one haploid mouse genome, using primer pair Frax C and 
Frax F. No PCR product was visible on agarose gel electrophoresis at this stage. The 
second round of PCR was done using 1 µl of the DNA generated from the first round 
PCR and primer pair Frax m5 and Frax m4 (Frax m4- labeled with 6-carboxyfluorescein 
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(FAM)). The PCR product from the second round was then resolved on an ABI 3130XL 
Genetic Analyzer and the data analyzed using GeneMapper 4.0 software, as detailed in 
the Materials and Methods chapter. 
Analysis of 3-month-old animals showed that the number of expanded alleles 
observed was significantly lower in the sperm of PolB+/C mice than in the sperm of 
PolB+/+ mice. Only 42% of the alleles from gametes of PolB+/C mice were larger than the 
parental allele compared to 74% in PolB+/+ mice (p=0.0001) (Figure 4.2). We also 
observed an increase in proportion of contractions in the gametes of PolB+/C mice (37% 
versus 7% of alleles, p=0.0001). The proportion of unchanged alleles, alleles that were 
the same size as the parental allele, was similar in both PolB+/C and PolB+/+ mice (21% 




Figure 4.2 Role of Y265C mutation in PolB on intergenerational instability in 
gametes of 3 months mice. The proportion of expansions, contractions and 
unchanged alleles in PolB+/+ and PolB+/C male mice. The 95% confidence interval is 
represented by the error bars. The asterisks indicate the P value by Fisher’s exact test 
(*p <0.01 and ** p<0.0001). 
 
While the total number of expansions was reduced, we found that PolB+/C mice 
had more larger expansions with 22 % of expansions involving the addition of more than 
10 repeats in the gametes of PolB+/C mice compared to only 3% in the gametes of wild 
type mice (Figure 4.3). We also noticed that the size of contractions was larger in 
PolB+/C mice compared to wild type mice (Figure 4.3). The average size of contractions 
was 19.68 repeats in the sperm of PolB+/C mice and 10.83 repeats in the sperm of 
PolB+/+ mice. However, the difference between the two genotypes was not statistically 
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significant because of some very large contractions that were seen in the PolB+/C mice 





Figure 4.3 The profile of repeat length changes in the gametes of PolB+/+ and 
PolB+/C young mice. Graph showing the proportion of alleles with the indicated change 
in repeat length for PolB+/+ and PolB+/C gametes of 3-month-old male mice. Inset: Graph 
showing different classes of repeat size in PolB+/+ and PolB+/C mice. The 95% 
confidence interval is represented by the error bars. The asterisks indicate the allele 




In the sperm of 11-month-old PolB+/+ and PolB+/C mice more than 90% of alleles 
had expanded (Figure 4.4). Since in 3 month old PolB+/C mice, the proportion of 
gametes that had undergone at least one round of expansion was 42%, the fact that in 
11 month old PolB+/C mice ~90% of gametes revealed evidence of at least one round of 




Figure 4.4 Role of Y265C mutation in PolB on intergenerational instability in the 
gametes of 11 months mice. The proportion of expansions, contractions and 
unchanged alleles in PolB+/+ and PolB+/C male mice. The 95% confidence interval is 




The excess of large expansions seen in 3 month old PolB+/C mice was even 
greater in the gametes of 11 month old animals (Figure 4.5) with 39% of the expanded 
gametes having added >15 repeats compared to 9 % in PolB+/+ mice (Figure 4.5, inset). 
Furthermore, in the gametes of PolB+/C mice, the distribution profile of all expansions 
showed local maxima representing the gain of 10,16, 21, and 27 repeats (Figure 4.5). 
This pattern would be in agreement with the idea that most expansions in the gametes 
of PolB+/C mice result in the addition of an average of 5 to 6 repeats, with the gametes 
of 11-month-old animals already having undergone more than one round of expansion. 
In contrast, the average number of repeats added in PolB+/+ mice was 1-2 repeats. Our 
data suggest that while the Y256C mutation lowers the frequency of repeat expansion, 




Figure 4.5 The profile of repeat length changes in germ line of gametes of PolB+/+ 
and PolB+/C older mice. Graph showing the proportion of alleles with the indicated 
change in repeat length for PolB+/+ and PolB+/C gametes of 11-month-old male mice. 
Inset: Graph showing different classes of repeat size in PolB+/+ and PolB+/C mice. The 
95% confidence interval is represented by the error bars. The asterisks indicate the 
allele classes that are significantly different by Fisher’s exact test (*p < 0.01). 






The aim of this research was to assess whether events downstream of DNA 
nicking in the BER pathway are involved in the expansion of the FX PM repeats. We 
have shown that heterozygous mutation for the PolB Y265C mutation causes a 
significant decrease in the extent of somatic expansion in 16 month old mice (Figure 
4.1). However, not all expansion-prone tissues tested were affected by the presence of 
the PolB Y265C mutation, expansions were reduced in the tail taken at euthanasia and 
the testis only. This is consistent with previous findings on the limited effect of PolB 
mutations on the mutation rates of different tissues (ALLEN et al. 2008), an observation 
that has been interpreted to mean that DNA repair in most tissues is not sensitive to 
PolB heterozygosity. We also have shown that heterozygosity for the PolB Y265C 
mutation significantly reduces the intergenerational expansion frequency in young FX 
PM mice (Figures 4.2 and 4.3). While the number of expansions seen in older PolB 
heterozygous mice was not significantly different from WT animals (Figure 4.4), this is 
likely due to the fact that the number of expansions has reached a maximum.  
While the mechanism by which BER pathway promotes repeat expansion 
remains to be elucidated, it has been suggested based on in vitro experiments that 
expansion can arise during long patch BER either via a “hit and run” mechanism 
involving limited Polβ strand displacement and FEN1 flap excision of the nucleotide 
linked to the 5′-sugar phosphate group as illustrated in Figure 4.6i. The use of such a 
pathway might be expected to produce only small expansions since Polβ is not very 
processive and does not result in extensive strand displacement synthesis. An alternate 
  
 88 
model suggests that expansion result from the use of an alternate LP-BER sub-pathway 
that involves the coordinated DNA synthesis by Polβ and Polδ or Polε, followed by 
FEN1 flap cleavage (LIU AND WILSON 2012; CHAN et al. 2013) as illustrated in Figure 
4.6ii. Since Polδ is more processive it is more likely to result in strand-slippage. In the 
presence of Polβ priming may be more likely to occur from the slipped position since 
Polβ lacks the appropriate proofreading ability necessary for removal of the slipped 
strand. In addition, Polδ causes more extensive strand displacement than Polβ. Thus, 
the use of this pathway may be expected to produce larger expansions. Our data on the 
differential effect of the Y265C mutation on the occurrence of large and small 
expansions (Figures 4.3 and 4.5) might reflect the contribution of these different 
mechanisms to repeat expansion in the FX PM mice. It is possible that the small 
expansions (Figure 4.3) observed in our mice result from the incorporation of few 
additional nucleotide bases into DNA strand during repair by the LP-BER branch that is 
dependent on the weak strand-displacement activity of Polβ as illustrated in Figure 4.6i, 
whereas large expansions may arise from the incorporations of several nucleotide 
bases in the repaired strand by LP-BER branch that is dependent on more extensive 
strand displacement by Polδ/Polε as shown in Figure 4.6ii. Our data suggest that 




Figure 4.6 BER-model of expansion in the PM mouse of the FXDs. The repair of 
DNA damage within the repeat initiated by DNA glycosylases in response to oxidized 
bases. The short patch BER sub-pathway can repair a native 5’ -sugar phosphate 
group. Nicks unrepaired by SP- BER will be processed by either one of the two sub-
pathways of the LP BER: (i) In one LP BER pathway (left), the processing of nicks is 
done by Polβ gap-filling synthesis, followed by cleavage of the small DNA flap by FEN1. 
A 5’end that can be ligated is generated and still contains few additional bases. This 
pathway is also referred to as “hit and run” mechanism of BER and generates small 
expansions. (ii) The LP BER pathway (right) that involves the use of Polβ or Polδ, and 
Polε. In this pathway repair is mediated by an inefficient strand displacement by Polβ or 
more extensive strand displacement by Polδ or Polε, followed by the creation of a 
ligatable 5’ end that also still contains more flap bases by FEN1  (shown in orange). 
This pathway generates larger expansions. Modified from Zhao and Usdin, 2015. 
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Chapter 5:  Conclusions  
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5.1  Conclusions 
The aim of my thesis work was to more fully characterize the somatic instability 
of PM alleles and examine the involvement of DNA repair proteins MSH2, MSH6, and 
Polβ in CGG•CCG repeat expansion in somatic cells and on intergenerational 
transmissions in the FX PM mouse model. In this thesis, I described factors important 
for CGG•CCG repeat expansion using this mouse model and a lymphoblastoid cell line 
from a human PM carrier. The novel discoveries of this research thesis have been 
categorized into four sections: 
 Firstly, we showed for the first time that somatic expansion could occur in human 
PM cells in tissue culture converting the PM allele gradually over a period of time of ~2 
years into a FM allele (Figure 2.2). Somatic expansion may have clinical significance 
since the gravity of the disease symptoms is related to the number of repeats.  
Secondly, we showed that somatic expansion in the FX PM mouse was more 
prominent in male than in female mice and that this gender difference was due in part to 
X chromosome inactivation in females (Figure 2.9). Specifically, we showed that 
somatic expansion occurred exclusively on PM allele that was located on the active X 
chromosome of female mice, suggesting that either an open chromatin configuration or 
the transcriptional activity of the gene is necessary for expansion. In fact, transcription 
has been previously proposed to play a role in repeat expansion based on observations 
made of the expansion rates seen in different lines of transgenic mouse models of DM1 
and HD (LIA et al. 1998; GOULA et al. 2012). However, since chromosomal context 
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affects expansion and the chromosomal context of the transgenes being compared in 
these cases differed from one another, it was not possible to definitively implicate 
transcription/open chromatin in expansion based on these experiments. However, since 
Fmr1 is an X-linked gene, we were able to compare simultaneously the extent of 
expansion of the same PM allele in the same sequence context on the active and 
inactive X chromosome in the same animal. Thus our data allowed us to definitively 
demonstrate a requirement for transcription and/or an open chromatin configuration in 
the FX expansion in mice. A role for transcriptionally competent chromatin is also 
consistent with the observation that large, unmethylated human alleles are unstable 
(GLASER et al. 1999) and suggests that at least some of this instability reflects 
expansions of smaller alleles rather than contraction of larger ones. 
However, when colleagues in the Usdin laboratory measured the amounts of 
Fmr1 mRNA in five different expansion prone tissues, no good correlation was seen 
between the amount of transcription and the degree of somatic expansion in our mice 
(LOKANGA et al. 2013). It might be that while transcription or an open chromatin 
conformation is essential, it is not enough by itself to promote expansion; other factors 
or processes associated with transcription might be rate-limiting.  
Thirdly, my work showing that expansion of the CGG•CCG repeat in our mice 
was dependent on the parental Msh2 gene dosage and not that of the offspring. This 
suggests that expansion of the FX repeat most likely occurred in the gametes. Given 
that the oocyte does not divide, this lends support to the idea that the expansion 
mechanism does not involve a problem with chromosome replication per se and that a 
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mechanism involving aberrant DNA repair and/or recombination is likely to account for 
repeat expansion.  I also demonstrated the involvement of MutSα in the generation of 
both germ line and somatic expansion in the FX PM mice. However, since data 
generated by colleagues in the Usdin laboratory have shown that loss of MSH3 
(therefore, MutSβ) abolished almost all expansions (ZHAO et al. 2015), MutSα must be 
acting in a predominantly MutSβ-dependent manner.  
Fourthly, I also showed that expansions were significantly reduced in the paternal 
gametes of young mice (Figure 4.2) and in the tail and testis tissues of FXD mice that 
were heterozygous for a Y265C mutation in PolB gene (Figure 4.1). Thus expansion 
involves central events in the BER pathway. We have shown in chapter 3 of this thesis 
that MSH2 and MSH6 (thus, MutSα) contribute to the generation of expansions in our 
mouse model. Thus, it might be that these two pathways interact to generate expansion. 
However, the mode of interaction between the components of these two pathways to 
generate expansions remains an open question. It might be that MutSα is acting 
downstream of DNA damage excision to stabilize the hairpins formed during strand-
slippage and strand-displacement synthesis that is mediated by Polβ or Polδ, and Polε. 
It can also perhaps interfere with the removal of these hairpins by enzymes like FEN1 
(SPIRO et al. 1999). This interference could result in the hairpins being channeled into a 
different repair pathway that results in expansions (ZHAO AND USDIN 2015)  
Thus our findings lend credence to the idea that MMR and BER pathways 
interact to promote expansion (KOVTUN et al. 2007; MCMURRAY 2010). However, more 
work is needed to understand just how these pathways interact to generate expansions 
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in the FXDs in particular, and in the Repeat Expansion Disorders in general. Taken all 
together, my research findings have shed significant new light on the mechanisms of 
repeat expansion in the FXDs. 
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6.1 Mouse maintenance and breeding 
Generation of the FXPM mice and of Msh2, Msh6, and PolB mutant mice was 
described previously (REITMAIR et al. 1995; EDELMANN et al. 1997; ENTEZAM et al. 2007; 
SENEJANI et al. 2012). Mice were kept on a predominantly C57BL/6J genetic 
background. However, in the effort to generate PolB homozygous mutant mice, we also 
backcrossed some mice for 4 generations onto a 129S1 background. They were all 
maintained in accordance with “the guidelines of the NIDDK Animal Care and Use 
Committee and with the Guide for the Care and Use of Laboratory Animals” (NIH 
publication no. 85-23, revised 1996). Newborn mice were weaned at 3 weeks of age 
and mice were tagged with a number for identification on the ear. Tail snips (~<5 mm) 
were taken at this time using local anesthesia with ethyl chloride. Mice were euthanized 
when necessary by CO2 inhalation followed by cervical dislocation. 
To generate FXPM mice with mutations in either MMR gene (Msh2 and Msh6) or 
the BER gene, POLB, we crossed FX PM mice with ~147 repeats with mice carrying 
null alleles (knockouts) of Msh2 and Msh6 and mice having a hypomorphic mutation in 
POLB to generate animals carrying a single copy of the Fmr1 PM allele that were wild 
type (WT), heterozygous, or homozygous for Msh2 or Msh6 and heterozygous for the 
POLB mutation.   
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6.2 DNA isolation 
Genomic DNA was extracted from mouse-tail samples using KAPA genotyping 
kits (Cat # AS1120; KAPA BIOSYSTEMS, Wilmington, MA) according to the 
manufacturer’s recommendations. The salting out method for isolation DNA from tail 
and sperms was also sometimes used. Briefly, 180 µl of tissue lysis buffer (buffer ATL # 
19076, Qiagen, Valencia, CA) and 20 µl of proteinase K (50 mg/ml) were added to the 
tails in 1.7 ml microfuge tubes. The tubes were briefly vortexed and incubated overnight 
at 55°C. The next day, the tubes were briefly centrifuged to bring any liquid to the 
bottom of tubes and 60 µl of 5 M NaCl was then added. Subsequently, samples were 
mixed well by inverting the tubes 10 times, and then spun down at maximum speed 
(~14000 rpm) for 10 minutes at ambient temperature (~73°F). Afterward, 260 µl of the 
supernatant was transferred to a new microfuge tube and 260 µl of 100% ethanol was 
added to the supernatant. The samples were once more spun down for 10 minutes. 
After the removal of the ethanol, the DNA pellets were then washed with 1 ml of 70% 
ethanol. The DNA pellets were then air dried for about 10 minutes before being 
resuspended in 50-100 µl of TE buffer. DNA samples were stored at 4°C. A DNA 
isolation kit (Maxwell 16, Promega, Madison, WI) was also used for the extraction of 
genomic DNA from different mouse tissues. 
The concentrations of the genomic DNA were determined using a Denovix DS-11 
spectrophotometer (Denovix, Wilmington, DE). The concentration of samples was 
determined based on their absorbance (A) at 260 nm and their purity was verified by 
analyzing A260/280 ratio. In order to verify the integrity of the genomic DNA, we 
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electrophoresed ~100 ng of the genomic DNA on a 0.7% agarose gel along with λ 
DNA/Hind III molecular weight marker (cat # 15612-013; Life Technologies, Grand 
Island, NY). After staining with ethidium bromide the DNA was visualized on a 
FluorChem M gel imager (Proteinsimple, San Jose, CA). 
6.3 Genotyping 
The primers used for genotyping are listed in Table 1. Primers were all obtained 
from Integrated DNA Technologies (IDT, Coralville, IA). The PCR conditions are 
summarized in Table 2. FX PM genotyping in mice were carried out using a PCR assay 
as previously described (LAVEDAN et al. 1998) and shown in Table 2. The binding sites 
for the primers used in this assay are found immediately adjacent to the repeat tract and 
their 3’ ends are specifically unique to the PM allele. Another primer pair, Frax C and 
Frax F, that detect both wild type (WT) Fmr1 and FX premutation alleles, was used for 
genotyping (FU et al. 1991). For the analysis of repeat size in the human cell line, we 
used Frax AR and Frax F primer pair. Frax F was labeled with 4, 7, 2′, 4′, 5′, 7′-
hexachloro-6-carboxyfluorescein (HEX). The PCR products were separated by 
electrophoresis on a 1.5% agarose gel, stained and visualized as described above. 
Msh2, Msh6, and POLB genotyping was also carried out by Polymerase Chain 
Reaction (PCR) analysis of tail genomic DNA, as described previously (REITMAIR et al. 
1995; EDELMANN et al. 1997; SENEJANI et al. 2012) and shown in Table 2. The PCR 
products were resolved by electrophoresis on a 1.5% agarose gel, stained and 
visualized as described above.  
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Table 6.1 Primers used for genotyping. 
 
























Y265-F1 AGAAAAGCAGCTTCCAGCAG (SENEJANI et 
al. 2012) Y265-R4 CAGACTTTCCAAGTGCAGGAT 





Table 6.2 PCR conditions used for genotyping. 
 
PCR  Reaction Mix Cycling conditions Fragment size 
CGG 
Reagents                   PCR reaction  Steps             Conditions  
~480bp 
















95°C; 3 min 
95°C; 15 sec 
65°C; 15 sec 
72°C; 15 sec 
72°C; 10 min 
(step 2-4 x 35 cycles) 
Msh2 


























95°C; 15 sec 
55°C; 30 sec 
72°C; 10 sec 
72°C; 10 min 
(step 2-4 x 5 cycles) 
Msh6 
























95°C; 3 min 
95°C; 15 sec 
60°C; 15 sec 
72°C; 15 sec 
72°C; 10 min 
(step 2-4 x 30cycles) 
PolB 

























95°C; 15 sec 
55°C; 30 sec 
72°C; 10 sec 
72°C; 10 min 
(step 2-4 x 30cycles) 
     bp = base pairs, I = initial denaturation, II = denaturation, III = annealing, 




6.4 Repeat analysis 
In order to determine the repeat number in each animal, the CGG•CCG repeat-
tract was amplified using ~100 ng of genomic DNA from tail or mouse tissues by PCR 
as described above for the PM genotyping of the animals except that the Frax m4 
primer was labeled with either 6-carboxyfluorescein (FAM) or 4, 7, 2′, 4′, 5′, 7′-
hexachloro-6-carboxyfluorescein (HEX). Two microliters of the PCR product was mixed 
with 10 µl HiDi Formamide and 0.5 µl of GeneScan LIZ 600™, LIZ1200™ or Rox 500™ 
size standard (Applied Biosystems, Carlsbad, CA). The mixture was denatured at 95°C 
for 3 minutes and chilled immediately on ice, then resolved by capillary electrophoresis 
on an ABI Genetic Analyzer (Applied Biosystems). The PCR profiles were analyzed 
using GeneMapper Software v4.0  
For analysis of intergenerational instability, the repeat size in the tail DNA taken 
at weaning (3 weeks of age) from each animal was compared to the repeat size of the 
tail DNA of the transmitting parent taken at the same age to determine whether 
expansion or contraction had occurred. In the case of somatic instability analysis, the 
repeat size in adult mouse tissue at the time of euthanasia was compared to the repeat 
size of the same animal in the tail taken at weaning. To quantify the degree of 
expansion in various organs of our mice, the somatic instability index from different 
organs was computed as previously described (LEE et al. 2010) with some modification. 
Briefly, the highest peak in the Gene Mapper profile of each sample analyzed was 
identified and peaks with heights less than 10% of this peak were excluded from further 
analysis. “The peak height was standardized by dividing the peak height of each peak 
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by the sum of the heights of all peaks. The normalized peak heights were then 
multiplied by the changes from the original allele, and these values were summed to 
generate the instability index”(LEE et al. 2010; HAMLIN et al. 2011). The change in repeat 
length of each peak was calculated from the highest peak in the tail sample determined 
in the mouse at 3 weeks of age (main allele), or in the heart sample determined at time 
of death since we have found that somatic instability is minimal in heart, and thus the 
main allele in the heart of an adult mouse is similar to the main allele in the tail taken at 
3 weeks 
6.5 The XCI assay 
We developed a methylation–sensitive PCR assay to distinguish the repeat 
profile present on PM alleles located on active X chromosomes from those on inactive 
ones. The assay is based on the fact that the Frax m5 primer, one of the primers used 
for the genotyping of the PM allele and determination of repeat number in the FX PM 
PCR, contains a recognition site for Sau96I, a restriction enzyme sensitive to 
methylation. Therefore, digestion of DNA with Sau96I will eliminate PM alleles found on 
the active X chromosome. 
10 U of Sau96I restriction enzyme was used to digest one microgram  (1 µg) of 
genomic DNA in a total volume of 50 µl for 4 hours at 37°C in 1x buffer 4 (New England 
Biolabs, Ipswich, MA). For each sample an undigested control was similarly prepared 
without the enzyme. To monitor the extent of digestion, 500 ng of pUC19, a plasmid that 
has 6 Sau96I recognition sites was added to each genomic DNA sample. Samples were 
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monitored by agarose gel electrophoresis to confirm complete digestion of the plasmid. 
The reaction mixes were then heated at 65°C for 20 minutes to inactivate the enzyme. 
Following DNA digestion, 2 µl (~100 ng) of the digest and undigested DNA was used in 
the FX PM PCR assay. Two microliters of the PCR product was then mixed with 10 µl 
HiDi Formamide and 0.5 µl of LIZ1200™ size standard. The mixture was denatured at 
95°C for 3 minutes and chilled immediately on ice, and the PCR products were 
analyzed as described above. 
6.6 X inactivation ratio assay 
Since amplification across the repeat tract is not quantitative, we needed a 
different assay to determine the degree of XCI skewing. Therefore, we designed a 
different methylation-sensitive PCR based assay that take advantage of the cleavage 
site for the restriction enzyme EaeI found in the neomycin marker that was part of the 
construct used to generate the FX PM mouse line (ENTEZAM et al. 2007). This marker is 
located in intron 1 and DNA digestion by EaeI will occur only if the template is located 
on the active X chromosome. 
One microgram of genomic DNA was incubated in 1x CutSmart buffer (New 
England Biolabs, Ipswich, MA) with 10 U of the restriction enzyme EaeI (New England 
Biolabs) 4 hours at 37°C. The enzyme was heat inactivated for 20 minutes at 65°C. 
Following DNA digestion, quantitative real-time PCR (qRT-PCR) was performed using 
power SYBR master mix (Applied Biosystems) in a real time PCR machine (StepOne 
Plus, Applied Biosystems). qRT-PCR reactions were performed in 96-well plates 
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(MicroAmp fast # 4346907, Applied Biosystems, Carlsbad, CA) in triplicate. A final 
volume of 20 µl master mix was prepared containing 10 µl of 2x power SYBR master 
mix (Applied Biosystems, Carlsbad, CA), 0.4 µl of 10 µM XCI-TF and XCI-TR primers 
(Table 3), 7.2 µl of water and 2 µl of the digested DNA (or undigested DNA). 
A control reaction for EaeI restriction enzyme digestion was also included. The 
reaction was done using primer pairs XCI-CF and XCI-CR that amplifies a region just 
upstream of the target amplicon (EaeI sensitive amplicon). This region has an EaeI site 
that does not contain CpG residues and is consequently digested whether the region is 
methylated or not. The EaeI-sensitive PCR (target) and control master mixes were 
prepared separately and added to the 96 wells reaction plate (MicroAmp Fast, Applied 
Biosystems) with an automatic repetitive pipette (Rainin AutoRep E, Rainin, Oakland, 
CA), followed by adding the digested or undigested DNA. The real time plate was then 
sealed with a plate sealer (MicroAmp, Applied Biosystems, Carlsbad, CA). The mixtures 
were then mixed gently and bubbles removed by gently tapping the bottom of the wells. 
Subsequently, the plate was briefly spun down at 1000 rpm to bring all the liquid to the 
bottom of the wells. The PCR conditions are provided in Table 4. The yield of the EaeI 
digested methylation sensitive amplicons relative to undigested material was calculated 




Table 6.3 Primers used in XCI methylation assay. 
 




XCI-TF TGGACGAAGAGCATCAGGGG 268bp 
XCI-TR GCGATACCGTAAAGCACGAG 
EaeI- Control 
XCI-CF CGGTTCTTTTTGTCAAGACCGA 195bp 
XCI-CR CAGGAGCAAGGTGAGATGACA 
T= target, C= control, F= forward, R= reverse, bp= base pair 
Table 6.4 qRT-PCR conditions for XCI assay 
 
PCR name Reaction Mix Cycling conditions 
    
Target/control 
Reagent        Vol (µl) Step Conditions 
H2O 7.2 µl I         95°C; 3 min 
2x power SYBR mix  10 µl II 95°C; 15 sec 
XCI-F/XCI-CF  0.4 µl III 60°C; 15 sec 
XCI-TR/ XCI-CR  0.4 µl  IV 72°C; 15 sec 
  V 72°C; 10 min 
  (step 2-4 x 30cycles) 
I= initial denaturation, II= denaturation, III= annealing, IV= elongation 




6.7 Western blotting 
6.7.1 Protein extraction and quantification 
~ 20 mg of mouse tissues were emulsified using a tissue homogenizer (Precellys 
24, Bertin Technologies, Rockville, MD) with T-PER (total lysate) or NE-PER (nuclear 
fraction) protein extraction reagents (Pierce Biotechnology, Rockford, IL) supplemented 
with phosphatase inhibitor cocktail-3 (Sigma-Aldrich, St. Louis, MO) and protease 
inhibitor cocktail (Roche Applied Science, Indianapolis, IN) according to the data sheet 
of the product and the manufacturer ‘s instructions. Bradford assay, a colorimetric 
protein assay (REISNER et al. 1975), was used to determine the protein concentration 
using either a Bio-Rad protein assay kit (cat # 500-0205; Bio-Rad, Hercules, CA) or a 
Coomassie Plus-The Better Bradford assay kit (cat # 1856268; Pierce Biotechnology, 
Rockford, IL) according to the manufacturer’s recommendations. 
Briefly, using the Bio-Rad kit, one milliliter of Bradford reagent was mixed with 5 
µl of the sample in a plastic disposable cuvette, incubated for 5 minutes at room 
temperature and absorbance read at 595 nm in a spectrophotometer. To measure the 
protein concentration using the Pierce kit, 1.5 ml of Bradford reagent was mixed with 5 
µl of samples in a disposable cuvette as well and incubated for 10 minutes at room 
temperature. A calibration curve was generated each time a protein assay was 
performed with Bovine Serum Albumin (BSA) dilutions of known concentrations. 
   
 
 107 
6.7.2 Polyacrylamide gel electrophoresis and Western blotting 
Polyacrylamide gel electrophoresis of SDS-denatured proteins was performed 
using the Novex NuPAGE SDS-PAGE gel system, a high-performance denaturing 
polyacrylamide gel electrophoresis system (Life Technologies, Carlsbad, CA). Twenty to 
30 µg proteins were resolved on either a 3-8% Novex Tris-Acetate protein or 4-12% 
Novex Bis-Tris gels (Life Technologies Carlsbad, CA) and transferred onto 
nitrocellulose membranes using 1X NuPAGE Transfer Buffer (Life Technologies) at 100 
V, at room temperature, for 1 hour. 10 % of methanol was added to the transfer buffer. 
After the protein transfer onto the membranes, the membranes were blocked for 1 hour 
in 5% ECL Prime blocking agent (GE Healthcare Bio-Sciences, Pittsburgh, PA) in 
1xTBST (10 mM Tris-HCl pH 7.5, 0.15 mM NaCl and 0.01% Tween 20) at room 
temperature, then probed with different antibodies as listed in table 5 overnight at 4°C. 
The membranes were then washed 3 times in 1xTBST (10 mM Tris-HCl pH 7.5, 0.15 
mM NaCl and 0.01% Tween 20). After incubation with the appropriate secondary 
antibody (anti-rabbit or anti-mouse), the membranes were once again washed 3 times in 
1xTBS. The FluorChem M imaging system (Proteinsimple, Santa Clara, CA) was used 
to detect the protein on the membrane. Prior to protein detection, ECL Prime detection 


























































































































































































































































































































































































































































































































































































































































































































6.8 ELISA essay: 
ELISA essays were done using the MSH3 ELISA kit (cat # MBS9326679, 
MyBioSource, San Diego, CA) according to the manufacturer’s recommendations. 
Briefly, mouse tissues were emulsified using a tissue homogenizer (Precellys 24, Bertin 
Technologies, Rockville, MD) in 1X PBS. The homogenates were then spun down for 
15’ at 500g. The supernatant is then collected. Fifty microliters of standards of known 
concentrations are added in standard wells and 50 µl of each sample added to sample 
wells of the 96 wells ELISA plate pre-coated with MSH3. One hundred microliters of 
HRP-conjugate reagent was added to each well and the mixture incubated for 60 
minutes at 37˚C. The liquid was then drained off and the plate washed 4 times with the 
wash solution provided in the kit. Chromatogen solutions (solution A and B provided in 
the kit) were then added to all wells followed by 15 minutes incubation in the dark. The 
plate was then read at 450 nm using a Model 680 microplate reader (Bio-Rad 
Laboratories). 
6.9 Statistical analysis 
A web version of the GraphPad QuickCalcs Software (http://www.graphpad.com) 
was used to perform statistical evaluation of our data. . Fisher‘s exact test was used in 
the evaluation of the frequency of expansions, contractions and unchanged alleles. 
Comparison of continuous data sets was done by the Student‘s t test. In some 
circumstances, the 95% confidence interval (95% Cl) was estimated for the amount of 
expansions, contractions and unchanged alleles using the GraphPad implementation of 
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the modified Wald method (http://www.graphpad.com). All calculated P-values are two-
tailed and a P-value of <0.05 was considered as significant. 
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